Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:benzothiazine
go back to main search page
Accession:CHEBI:46899 term browser browse the term
Synonyms:related_synonym: benzothiazines


show annotations for term's descendants           Sort by:
meloxicam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions ISO Meloxicam inhibits the reaction [Doxorubicin results in increased activity of ABCB1 protein]; Meloxicam inhibits the reaction [Doxorubicin results in increased expression of ABCB1 protein] CTD PMID:15501994 NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 affects binding ISO ABCC4 protein binds to meloxicam CTD PMID:17939016 NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283 		JBrowse link
G Abl1 ABL proto-oncogene 1, non-receptor tyrosine kinase multiple interactions ISO [Meloxicam co-treated with Cilostazol] results in decreased expression of ABL1 protein CTD PMID:35920412 NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO [Meloxicam co-treated with Cilostazol] results in decreased phosphorylation of AKT1 protein CTD PMID:35920412 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G App amyloid beta precursor protein multiple interactions ISO meloxicam inhibits the reaction [Aluminum results in increased expression of APP protein] CTD PMID:16928369 NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression
multiple interactions		 ISO meloxicam results in increased expression of BAX protein
[Cilostazol co-treated with Meloxicam] results in increased expression of BAX mRNA		 CTD PMID:19709125 PMID:35920412 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Bdkrb1 bradykinin receptor B1 multiple interactions EXP meloxicam inhibits the reaction [KNG1 protein binds to and results in increased activity of BDKRB1 protein] CTD PMID:11159707 NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747 		JBrowse link
G Casp3 caspase 3 increases activity
multiple interactions		 ISO
EXP		 Meloxicam results in increased activity of CASP3 protein
[Meloxicam co-treated with Cilostazol] results in increased activity of CASP3 protein
Meloxicam inhibits the reaction [Diquat results in increased expression of CASP3 protein modified form]
[Rutin co-treated with Meloxicam] affects the reaction [Formaldehyde affects the expression of CASP3 protein]; Meloxicam affects the reaction [Formaldehyde affects the expression of CASP3 protein]; Meloxicam inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]		 CTD PMID:19709125 PMID:24799355 PMID:29315975 PMID:29484840 PMID:35920412 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp9 caspase 9 multiple interactions
increases activity		 EXP
ISO		 Meloxicam inhibits the reaction [Diquat results in increased expression of CASP9 protein modified form]
[Meloxicam co-treated with Cilostazol] results in increased activity of CASP9 protein
Meloxicam results in increased activity of CASP9 protein		 CTD PMID:29484840 PMID:35920412 NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626 		JBrowse link
G Cat catalase multiple interactions
decreases expression		 ISO
EXP		 meloxicam inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]
Meloxicam affects the expression of and affects the activity of CAT protein
Meloxicam results in decreased expression of CAT protein		 CTD PMID:24799355 PMID:25034942 PMID:38036073 NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Chat choline O-acetyltransferase multiple interactions ISO meloxicam inhibits the reaction [Aluminum results in decreased expression of CHAT protein] CTD PMID:16928369 NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions ISO [CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Meloxicam] which results in increased chemical synthesis of Pyruvaldehyde; CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Meloxicam CTD PMID:33253783 NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312 		JBrowse link
G Ereg epiregulin multiple interactions ISO [meloxicam results in decreased activity of PTGS2 protein] inhibits the reaction [trans-10,cis-12-conjugated linoleic acid results in increased expression of EREG mRNA] CTD PMID:22583689 NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions ISO meloxicam inhibits the reaction [Paraquat results in decreased expression of GCLC protein] CTD PMID:20851755 NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544 		JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions ISO Meloxicam affects the expression of and affects the activity of GPX1 protein CTD PMID:38036073 NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024 		JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions ISO Meloxicam inhibits the reaction [HMGB1 protein results in increased expression of PTGS2 protein]; Meloxicam inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK1 protein]; Meloxicam inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK3 protein]; Meloxicam inhibits the reaction [HMGB1 protein results in increased phosphorylation of NFKBIA protein] CTD PMID:34755645 NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565
Ensembl chr16:5,901,586...5,978,565 		JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO [Rutin co-treated with Meloxicam] affects the reaction [Formaldehyde affects the expression of IL1B protein]; Meloxicam affects the reaction [Formaldehyde affects the expression of IL1B protein] CTD PMID:29315975 NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO meloxicam inhibits the reaction [Doxorubicin results in increased expression of IL6 protein] CTD PMID:24799355 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Kng1 kininogen 1 multiple interactions EXP Meloxicam inhibits the reaction [KNG1 protein binds to and results in increased activity of BDKRB1 protein] CTD PMID:11159707 NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO Meloxicam inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK1 protein] CTD PMID:34755645 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO Meloxicam inhibits the reaction [HMGB1 protein results in increased phosphorylation of MAPK3 protein] CTD PMID:34755645 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions ISO [Meloxicam co-treated with Cilostazol] results in decreased expression of MYC protein CTD PMID:35920412 NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions ISO meloxicam inhibits the reaction [Paraquat results in decreased expression of NFE2L2 protein] CTD PMID:20851755 NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions ISO Meloxicam inhibits the reaction [HMGB1 protein results in increased phosphorylation of NFKBIA protein] CTD PMID:34755645 NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941 		JBrowse link
G Park7 Parkinsonism associated deglycase multiple interactions ISO meloxicam inhibits the reaction [Paraquat promotes the reaction [Quinones binds to PARK7 protein]] CTD PMID:20851755 NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970 		JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression ISO meloxicam results in decreased expression of PCNA protein CTD PMID:19709125 NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995 		JBrowse link
G Prkaa1 protein kinase AMP-activated catalytic subunit alpha 1 multiple interactions ISO [Meloxicam co-treated with Cilostazol] results in increased expression of and results in increased phosphorylation of PRKAA1 protein CTD PMID:35920412 NCBI chr 2:54,240,298...54,275,978
Ensembl chr 2:54,240,137...54,275,978 		JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Meloxicam results in decreased activity of PTGS1 protein CTD PMID:25034942 NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 increases expression
decreases activity
multiple interactions		 ISO
EXP		 meloxicam results in increased expression of PTGS2 protein
meloxicam results in decreased activity of PTGS2 protein
Meloxicam inhibits the reaction [Diquat results in increased expression of PTGS2 protein]; Meloxicam inhibits the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone]
[meloxicam results in decreased activity of PTGS2 protein] inhibits the reaction [trans-10,cis-12-conjugated linoleic acid results in increased chemical synthesis of Dinoprost]; [meloxicam results in decreased activity of PTGS2 protein] inhibits the reaction [trans-10,cis-12-conjugated linoleic acid results in increased expression of EREG mRNA]; meloxicam inhibits the reaction [Aluminum results in increased expression of PTGS2 mRNA]; meloxicam inhibits the reaction [Aluminum results in increased expression of PTGS2 protein]
[Meloxicam results in decreased activity of PTGS2 protein] which results in decreased abundance of Dinoprostone; [Meloxicam results in decreased activity of PTGS2 protein] which results in decreased susceptibility to Chlorpyrifos; Meloxicam inhibits the reaction [HMGB1 protein results in increased expression of PTGS2 protein]		 CTD PMID:10791687 PMID:11159707 PMID:12417326 PMID:16928369 PMID:17164136 More... NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Scn5a sodium voltage-gated channel alpha subunit 5 decreases activity ISO Meloxicam results in decreased activity of SCN5A protein CTD PMID:33617802 NCBI chr 8:119,220,905...119,318,816
Ensembl chr 8:119,220,905...119,318,769 		JBrowse link
G Sell selectin L affects expression ISO meloxicam affects the expression of SELL protein CTD PMID:12147693 NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456 		JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions ISO Meloxicam affects the expression of and affects the activity of SOD1 protein CTD PMID:38036073 NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249 		JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions ISO Meloxicam affects the expression of and affects the activity of SOD2 protein CTD PMID:38036073 NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189 		JBrowse link
G Sord sorbitol dehydrogenase multiple interactions ISO [Rutin co-treated with Meloxicam] inhibits the reaction [Formaldehyde affects the activity of SORD protein]; Meloxicam inhibits the reaction [Formaldehyde affects the activity of SORD protein] CTD PMID:29315975 NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO meloxicam inhibits the reaction [Doxorubicin results in increased expression of TNF protein] CTD PMID:24799355 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
piroxicam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aars1 alanyl-tRNA synthetase 1 multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of AARS1 mRNA] CTD PMID:21858171 NCBI chr19:38,999,130...39,021,152
Ensembl chr19:38,999,163...39,021,147 		JBrowse link
G Abcd3 ATP binding cassette subfamily D member 3 decreases expression ISO Piroxicam results in decreased expression of ABCD3 mRNA CTD PMID:21858171 NCBI chr 2:209,852,087...209,905,763
Ensembl chr 2:209,852,087...209,906,020 		JBrowse link
G Acadvl acyl-CoA dehydrogenase, very long chain multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of ACADVL mRNA CTD PMID:21858171 NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075 		JBrowse link
G Ackr3 atypical chemokine receptor 3 decreases expression ISO Piroxicam results in decreased expression of ACKR3 mRNA CTD PMID:19192274 NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237 		JBrowse link
G Adipor2 adiponectin receptor 2 decreases expression ISO Piroxicam results in decreased expression of ADIPOR2 mRNA CTD PMID:21858171 NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355 		JBrowse link
G Adm adrenomedullin increases expression ISO Piroxicam results in increased expression of ADM mRNA CTD PMID:21858171 NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654 		JBrowse link
G Adora2a adenosine A2a receptor decreases expression ISO Piroxicam results in decreased expression of ADORA2A mRNA CTD PMID:19192274 NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386 		JBrowse link
G Agfg1 ArfGAP with FG repeats 1 decreases expression ISO Piroxicam results in decreased expression of AGFG1 mRNA CTD PMID:21858171 NCBI chr 9:84,124,845...84,182,615
Ensembl chr 9:84,125,120...84,178,128 		JBrowse link
G Aimp1 aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 decreases expression ISO Piroxicam results in decreased expression of AIMP1 mRNA CTD PMID:21858171 NCBI chr 2:221,151,907...221,175,458
Ensembl chr 2:221,151,904...221,175,728 		JBrowse link
G Ak2 adenylate kinase 2 increases expression ISO Piroxicam results in increased expression of AK2 mRNA CTD PMID:21858171 NCBI chr 5:141,308,650...141,364,633
Ensembl chr 5:141,346,063...141,364,632 		JBrowse link
G Akap12 A-kinase anchoring protein 12 multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of AKAP12 mRNA] CTD PMID:21858171 NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886 		JBrowse link
G Akr7a2 aldo-keto reductase family 7, member A2 decreases expression ISO Piroxicam results in decreased expression of AKR7A2 mRNA CTD PMID:21858171 NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909 		JBrowse link
G Aldh1a3 aldehyde dehydrogenase 1 family, member A3 decreases expression ISO Piroxicam results in decreased expression of ALDH1A3 mRNA CTD PMID:21858171 NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436 		JBrowse link
G Amigo2 adhesion molecule with Ig like domain 2 decreases expression ISO Piroxicam results in decreased expression of AMIGO2 mRNA CTD PMID:19192274 NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695 		JBrowse link
G Anp32a acidic nuclear phosphoprotein 32 family member A decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of ANP32A mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of ANP32A mRNA]		 CTD PMID:21858171 NCBI chr 8:62,829,099...62,865,443
Ensembl chr 8:62,827,456...62,865,443 		JBrowse link
G Anxa10 annexin A10 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of ANXA10 mRNA CTD PMID:21858171 NCBI chr16:27,738,712...27,805,648
Ensembl chr16:27,738,712...27,805,648 		JBrowse link
G Aplp2 amyloid beta precursor like protein 2 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of APLP2 mRNA] CTD PMID:21858171 NCBI chr 8:29,599,230...29,662,311
Ensembl chr 8:29,599,230...29,661,855 		JBrowse link
G Arc activity-regulated cytoskeleton-associated protein multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of ARC mRNA CTD PMID:21858171 NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378 		JBrowse link
G Arhgef2 Rho/Rac guanine nucleotide exchange factor 2 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ARHGEF2 mRNA] CTD PMID:21858171 NCBI chr 2:174,061,126...174,118,355
Ensembl chr 2:174,062,976...174,118,355 		JBrowse link
G Arl6ip5 ADP-ribosylation factor like GTPase 6 interacting protein 5 increases expression ISO Piroxicam results in increased expression of ARL6IP5 mRNA CTD PMID:21858171 NCBI chr 4:129,810,650...129,838,628
Ensembl chr 4:129,810,645...129,838,608 		JBrowse link
G Asf1a anti-silencing function 1A histone chaperone decreases expression ISO Piroxicam results in decreased expression of ASF1A mRNA CTD PMID:21858171 NCBI chr20:32,893,962...32,908,808
Ensembl chr20:32,893,573...32,908,808 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) increases expression ISO Piroxicam results in increased expression of ASNS mRNA CTD PMID:21858171 NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423 		JBrowse link
G Aspm assembly factor for spindle microtubules multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of ASPM mRNA] CTD PMID:21858171 NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755 		JBrowse link
G Atad2 ATPase family, AAA domain containing 2 decreases expression ISO Piroxicam results in decreased expression of ATAD2 mRNA CTD PMID:21858171 NCBI chr 7:89,634,123...89,676,738
Ensembl chr 7:89,634,123...89,676,738 		JBrowse link
G Atf3 activating transcription factor 3 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of ATF3 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ATF3 mRNA]		 CTD PMID:21858171 NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631 		JBrowse link
G Atf4 activating transcription factor 4 decreases expression ISO Piroxicam results in decreased expression of ATF4 mRNA CTD PMID:21858171 NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446 		JBrowse link
G Atp1b1 ATPase Na+/K+ transporting subunit beta 1 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ATP1B1 mRNA] CTD PMID:21858171 NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459 		JBrowse link
G Atp2a2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 decreases expression ISO Piroxicam results in decreased expression of ATP2A2 mRNA CTD PMID:21858171 NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101 		JBrowse link
G Atp5mc1 ATP synthase membrane subunit c locus 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of ATP5MC1 mRNA CTD PMID:21858171 NCBI chr10:81,024,056...81,026,780
Ensembl chr10:81,023,925...81,027,124
Ensembl chr10:81,023,925...81,027,124 		JBrowse link
G Atp6v1d ATPase H+ transporting V1 subunit D decreases expression ISO Piroxicam results in decreased expression of ATP6V1D mRNA CTD PMID:21858171 NCBI chr 6:97,656,725...97,672,295
Ensembl chr 6:97,656,576...97,672,303 		JBrowse link
G Aurka aurora kinase A decreases expression ISO Piroxicam results in decreased expression of AURKA mRNA CTD PMID:21858171 NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390 		JBrowse link
G Avpi1 arginine vasopressin-induced 1 multiple interactions ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of AVPI1 mRNA] CTD PMID:21858171 NCBI chr 1:240,930,236...240,936,154
Ensembl chr 1:240,930,236...240,936,154 		JBrowse link
G Bag5 BAG cochaperone 5 decreases expression ISO Piroxicam results in decreased expression of BAG5 mRNA CTD PMID:21858171 NCBI chr 6:130,768,467...130,772,122
Ensembl chr 6:130,768,141...130,772,970 		JBrowse link
G Bag6 BAG cochaperone 6 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of BAG6 mRNA CTD PMID:21858171 NCBI chr20:3,675,938...3,690,414
Ensembl chr20:3,675,938...3,688,657 		JBrowse link
G Bard1 BRCA1 associated RING domain 1 decreases expression ISO Piroxicam results in decreased expression of BARD1 mRNA CTD PMID:21858171 NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265 		JBrowse link
G Baz1a bromodomain adjacent to zinc finger domain, 1A decreases expression ISO Piroxicam results in decreased expression of BAZ1A mRNA CTD PMID:21858171 NCBI chr 6:72,389,701...72,512,516
Ensembl chr 6:72,389,703...72,512,459 		JBrowse link
G Bcar3 BCAR3 adaptor protein, NSP family member decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of BCAR3 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of BCAR3 mRNA]		 CTD PMID:21858171 NCBI chr 2:210,525,260...210,638,674
Ensembl chr 2:210,525,260...210,638,798 		JBrowse link
G Bccip BRCA2 and CDKN1A interacting protein multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of BCCIP mRNA] CTD PMID:21858171 NCBI chr 1:188,512,544...188,524,957
Ensembl chr 1:188,512,367...188,524,958 		JBrowse link
G Bcl2a1 BCL2-related protein A1 decreases expression ISO Piroxicam results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998 		JBrowse link
G Bclaf1 BCL2-associated transcription factor 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of BCLAF1 mRNA CTD PMID:21858171 NCBI chr 1:15,088,436...15,117,666
Ensembl chr 1:15,070,894...15,148,832 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions
increases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of BIRC5 mRNA] CTD PMID:21858171 NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380 		JBrowse link
G Bmp2k BMP-2 inducible kinase increases expression ISO Piroxicam results in increased expression of BMP2K mRNA CTD PMID:21858171 NCBI chr14:12,481,194...12,579,411
Ensembl chr14:12,484,729...12,579,134 		JBrowse link
G Brcc3 BRCA1/BRCA2-containing complex subunit 3 decreases expression ISO Piroxicam results in decreased expression of BRCC3 mRNA CTD PMID:21858171 NCBI chr 9:1,986,942...1,989,484
Ensembl chr 9:1,986,575...1,991,080 		JBrowse link
G Brms1 BRMS1, transcriptional repressor and anoikis regulator multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of BRMS1 mRNA CTD PMID:21858171 NCBI chr 1:202,345,766...202,355,028
Ensembl chr 1:202,345,704...202,355,028 		JBrowse link
G Bst2 bone marrow stromal cell antigen 2 decreases expression ISO Piroxicam results in decreased expression of BST2 mRNA CTD PMID:19192274 NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979 		JBrowse link
G Btg1 BTG anti-proliferation factor 1 multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of BTG1 mRNA] CTD PMID:21858171 NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649 		JBrowse link
G Bub1 BUB1 mitotic checkpoint serine/threonine kinase multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of BUB1 mRNA CTD PMID:21858171 NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650 		JBrowse link
G Bub1b BUB1 mitotic checkpoint serine/threonine kinase B multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of BUB1B mRNA] CTD PMID:21858171 NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547 		JBrowse link
G C1d C1D nuclear receptor corepressor multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of C1D mRNA CTD PMID:21858171 NCBI chr14:91,660,951...91,673,177
Ensembl chr14:91,660,989...91,672,852 		JBrowse link
G Cacybp calcyclin binding protein multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of CACYBP mRNA] CTD PMID:21858171 NCBI chr13:72,437,485...72,447,810
Ensembl chr13:72,437,490...72,450,177 		JBrowse link
G Cad carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CAD mRNA CTD PMID:21858171 NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861 		JBrowse link
G Cadm1 cell adhesion molecule 1 decreases expression ISO Piroxicam results in decreased expression of CADM1 mRNA CTD PMID:21858171 NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833 		JBrowse link
G Calm1 calmodulin 1 decreases expression ISO Piroxicam results in decreased expression of CALM1 mRNA CTD PMID:21858171 NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227 		JBrowse link
G Cand1 cullin-associated and neddylation-dissociated 1 increases expression ISO Piroxicam results in increased expression of CAND1 mRNA CTD PMID:21858171 NCBI chr 7:54,681,114...54,719,002
Ensembl chr 7:54,680,900...54,718,993 		JBrowse link
G Canx calnexin multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of CANX mRNA CTD PMID:21858171 NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821 		JBrowse link
G Capg capping actin protein, gelsolin like decreases expression ISO Piroxicam results in decreased expression of CAPG mRNA CTD PMID:21858171 NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856 		JBrowse link
G Capn7 calpain 7 decreases expression ISO Piroxicam results in decreased expression of CAPN7 mRNA CTD PMID:21858171 NCBI chr16:6,545,630...6,581,908
Ensembl chr16:6,545,731...6,581,905 		JBrowse link
G Capza2 capping actin protein of muscle Z-line subunit alpha 2 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of CAPZA2 mRNA] CTD PMID:21858171 NCBI chr 4:45,978,142...46,014,032
Ensembl chr 4:45,977,807...46,013,864 		JBrowse link
G Cast calpastatin increases expression ISO Piroxicam results in increased expression of CAST mRNA CTD PMID:21858171 NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659 		JBrowse link
G Cav1 caveolin 1 decreases expression ISO Piroxicam results in decreased expression of CAV1 mRNA CTD PMID:21858171 NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705 		JBrowse link
G Ccdc85b coiled-coil domain containing 85B increases expression ISO Piroxicam results in increased expression of CCDC85B mRNA CTD PMID:21858171 NCBI chr 1:202,763,645...202,764,660
Ensembl chr 1:202,763,631...202,764,703 		JBrowse link
G Ccl20 C-C motif chemokine ligand 20 decreases expression ISO Piroxicam results in decreased expression of CCL20 mRNA; Piroxicam results in decreased expression of CCL20 protein CTD PMID:19192274 NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629 		JBrowse link
G Ccn1 cellular communication network factor 1 increases expression ISO Piroxicam results in increased expression of CCN1 mRNA CTD PMID:19192274 NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484 		JBrowse link
G Ccn2 cellular communication network factor 2 decreases expression ISO Piroxicam results in decreased expression of CCN2 mRNA CTD PMID:21858171 NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734 		JBrowse link
G Ccn5 cellular communication network factor 5 increases expression ISO Piroxicam results in increased expression of CCN5 mRNA CTD PMID:19192274 NCBI chr 3:152,491,247...152,502,639
Ensembl chr 3:152,491,220...152,502,636 		JBrowse link
G Ccna2 cyclin A2 multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of CCNA2 mRNA] CTD PMID:21858171 NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577 		JBrowse link
G Ccnb1 cyclin B1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CCNB1 mRNA CTD PMID:21858171 NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172 		JBrowse link
G Ccnb2 cyclin B2 multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of CCNB2 mRNA] CTD PMID:21858171 NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874 		JBrowse link
G Ccnc cyclin C decreases expression ISO Piroxicam results in decreased expression of CCNC mRNA CTD PMID:21858171 NCBI chr 5:35,266,828...35,284,943
Ensembl chr 5:35,266,823...35,296,584 		JBrowse link
G Ccnd1 cyclin D1 increases expression ISO Piroxicam results in increased expression of CCND1 mRNA CTD PMID:21858171 NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602 		JBrowse link
G Ccnd3 cyclin D3 decreases expression ISO Piroxicam results in decreased expression of CCND3 mRNA CTD PMID:21858171 NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371 		JBrowse link
G Cd44 CD44 molecule increases expression ISO Piroxicam results in increased expression of CD44 mRNA CTD PMID:21858171 NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620 		JBrowse link
G Cd55 CD55 molecule (Cromer blood group) increases expression ISO Piroxicam results in increased expression of CD55 mRNA CTD PMID:21858171 NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831 		JBrowse link
G Cdc25a cell division cycle 25A decreases expression ISO Piroxicam results in decreased expression of CDC25A mRNA CTD PMID:21858171 NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701 		JBrowse link
G Cdc42 cell division cycle 42 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of CDC42 mRNA CTD PMID:21858171 NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111 		JBrowse link
G Cdc45 cell division cycle 45 decreases expression ISO Piroxicam results in decreased expression of CDC45 mRNA CTD PMID:21858171 NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619 		JBrowse link
G Cdc6 cell division cycle 6 increases expression ISO Piroxicam results in increased expression of CDC6 mRNA CTD PMID:21858171 NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011 		JBrowse link
G Cdca3 cell division cycle associated 3 multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of CDCA3 mRNA] CTD PMID:21858171 NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799 		JBrowse link
G Cdca4 cell division cycle associated 4 increases expression ISO Piroxicam results in increased expression of CDCA4 mRNA CTD PMID:21858171 NCBI chr 6:131,892,305...131,901,571
Ensembl chr 6:131,892,087...131,901,564 		JBrowse link
G Cdca8 cell division cycle associated 8 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of CDCA8 mRNA] CTD PMID:21858171 NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of CDK1 mRNA] CTD PMID:21858171 NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408 		JBrowse link
G Cdk2 cyclin dependent kinase 2 multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of CDK2 mRNA] CTD PMID:21858171 NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions
affects localization		 ISO [Cisplatin co-treated with Piroxicam] affects the localization of CDKN1A protein; [Cisplatin co-treated with Piroxicam] results in decreased expression of CDKN1A protein; [Piroxicam co-treated with Cisplatin] results in increased expression of CDKN1A mRNA; CDKN1A results in increased susceptibility to [Cisplatin co-treated with Piroxicam]
Piroxicam affects the localization of CDKN1A protein		 CTD PMID:21858171 NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B multiple interactions EXP Piroxicam inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] CTD PMID:12189186 NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A multiple interactions EXP Piroxicam inhibits the reaction [Azoxymethane results in decreased expression of CDKN2A mRNA]; Piroxicam inhibits the reaction [Azoxymethane results in decreased expression of CDKN2A protein] CTD PMID:12189186 NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149 		JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CDKN3 mRNA CTD PMID:21858171 NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in increased expression of CEBPB mRNA]
Piroxicam results in decreased expression of CEBPB mRNA		 CTD PMID:21858171 NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473 		JBrowse link
G Cebpg CCAAT/enhancer binding protein gamma multiple interactions
increases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of CEBPG mRNA]
Piroxicam results in increased expression of CEBPG mRNA		 CTD PMID:21858171 NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569 		JBrowse link
G Cenpa centromere protein A multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CENPA mRNA CTD PMID:21858171 NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675 		JBrowse link
G Cenpe centromere protein E decreases expression ISO Piroxicam results in decreased expression of CENPE mRNA CTD PMID:21858171 NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669 		JBrowse link
G Cep170 centrosomal protein 170 increases expression ISO Piroxicam results in increased expression of CEP170 mRNA CTD PMID:21858171 NCBI chr13:88,669,672...88,754,011
Ensembl chr13:88,670,358...88,732,226 		JBrowse link
G Cep55 centrosomal protein 55 decreases expression ISO Piroxicam results in decreased expression of CEP55 mRNA CTD PMID:21858171 NCBI chr 1:235,832,823...235,848,401
Ensembl chr 1:235,832,878...235,848,394 		JBrowse link
G Ces2h carboxylesterase 2H multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CES2 mRNA CTD PMID:21858171 NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830 		JBrowse link
G Ciz1 CDKN1A interacting zinc finger protein 1 multiple interactions
increases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of CIZ1 mRNA] CTD PMID:21858171 NCBI chr 3:15,658,479...15,673,762
Ensembl chr 3:15,658,539...15,673,762 		JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of CKS2 mRNA] CTD PMID:21858171 NCBI chr17:13,570,611...13,575,770 JBrowse link
G Clcn3 chloride voltage-gated channel 3 decreases expression ISO Piroxicam results in decreased expression of CLCN3 mRNA CTD PMID:21858171 NCBI chr16:29,127,152...29,200,133
Ensembl chr16:29,127,419...29,200,119 		JBrowse link
G Clgn calmegin decreases expression ISO Piroxicam results in decreased expression of CLGN mRNA CTD PMID:19192274 NCBI chr19:24,695,140...24,728,542
Ensembl chr19:24,696,875...24,728,758 		JBrowse link
G Cnn3 calponin 3 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of CNN3 mRNA] CTD PMID:21858171 NCBI chr 2:209,518,948...209,550,107
Ensembl chr 2:209,518,948...209,550,104 		JBrowse link
G Col1a1 collagen type I alpha 1 chain increases expression ISO Piroxicam results in increased expression of COL1A1 mRNA CTD PMID:19192274 NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624 		JBrowse link
G Colec12 collectin sub-family member 12 increases expression ISO Piroxicam results in increased expression of COLEC12 mRNA CTD PMID:19192274 NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618 		JBrowse link
G Cops3 COP9 signalosome subunit 3 decreases expression ISO Piroxicam results in decreased expression of COPS3 mRNA CTD PMID:21858171 NCBI chr10:44,618,115...44,652,807
Ensembl chr10:44,618,115...44,641,597 		JBrowse link
G Coq8a coenzyme Q8A multiple interactions
increases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of COQ8A mRNA] CTD PMID:21858171 NCBI chr13:91,904,731...91,933,588
Ensembl chr13:91,904,739...91,931,431 		JBrowse link
G Cpsf1 cleavage and polyadenylation specific factor 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of CPSF1 mRNA CTD PMID:21858171 NCBI chr 7:108,319,429...108,330,018
Ensembl chr 7:108,319,434...108,329,934 		JBrowse link
G Cpsf6 cleavage and polyadenylation specific factor 6 decreases expression ISO Piroxicam results in decreased expression of CPSF6 mRNA CTD PMID:21858171 NCBI chr 7:52,956,589...53,001,783
Ensembl chr 7:52,956,589...52,988,122 		JBrowse link
G Crk CRK proto-oncogene, adaptor protein multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CRK mRNA CTD PMID:21858171 NCBI chr10:60,530,469...60,556,703
Ensembl chr10:60,530,464...60,553,406 		JBrowse link
G Crtc3 CREB regulated transcription coactivator 3 increases expression ISO Piroxicam results in increased expression of CRTC3 mRNA CTD PMID:21858171 NCBI chr 1:134,552,830...134,655,929
Ensembl chr 1:134,554,696...134,655,500 		JBrowse link
G Csnk1a1 casein kinase 1, alpha 1 multiple interactions
increases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of CSNK1A1 mRNA] CTD PMID:21858171 NCBI chr18:55,017,049...55,050,184
Ensembl chr18:55,017,055...55,049,271 		JBrowse link
G Csnk2a2 casein kinase 2 alpha 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CSNK2A2 mRNA CTD PMID:21858171 NCBI chr19:9,556,443...9,596,080
Ensembl chr19:9,556,260...9,596,080 		JBrowse link
G Ctnnal1 catenin alpha-like 1 decreases expression ISO Piroxicam results in decreased expression of CTNNAL1 mRNA CTD PMID:21858171 NCBI chr 5:71,514,340...71,569,431
Ensembl chr 5:71,514,340...71,569,431 		JBrowse link
G Ctsc cathepsin C decreases expression ISO Piroxicam results in decreased expression of CTSC mRNA CTD PMID:21858171 NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387 		JBrowse link
G Cul4b cullin 4B decreases expression ISO Piroxicam results in decreased expression of CUL4B mRNA CTD PMID:21858171 NCBI chr  X:117,287,481...117,326,688
Ensembl chr  X:117,287,484...117,326,688 		JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 decreases expression ISO Piroxicam results in decreased expression of CXCL1 mRNA CTD PMID:19192274 NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 increases expression
decreases expression		 ISO Piroxicam results in increased expression of CXCL2 mRNA
Piroxicam results in decreased expression of CXCL2 mRNA		 CTD PMID:19192274 PMID:21858171 NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 decreases expression ISO Piroxicam results in decreased expression of CXCL1 mRNA CTD PMID:19192274 NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511 		JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 decreases expression ISO Piroxicam results in decreased expression of CXCR4 mRNA CTD PMID:19192274 NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883 		JBrowse link
G Cyb5b cytochrome b5 type B decreases expression ISO Piroxicam results in decreased expression of CYB5B mRNA CTD PMID:21858171 NCBI chr19:35,062,871...35,096,741
Ensembl chr19:35,062,813...35,098,249 		JBrowse link
G Cyfip2 cytoplasmic FMR1 interacting protein 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CYFIP2 mRNA CTD PMID:21858171 NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 multiple interactions
decreases activity
decreases expression		 ISO Piroxicam inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA]
Piroxicam results in decreased activity of CYP19A1 protein
Piroxicam results in decreased expression of CYP19A1 mRNA		 CTD PMID:15964185 PMID:19147701 NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758 		JBrowse link
G Dbf4 DBF4-CDC7 kinase regulatory subunit increases expression
multiple interactions		 ISO Piroxicam results in increased expression of DBF4 mRNA
Cisplatin inhibits the reaction [Piroxicam results in increased expression of DBF4 mRNA]		 CTD PMID:21858171 NCBI chr 4:25,676,570...25,701,152
Ensembl chr 4:25,676,634...25,701,066 		JBrowse link
G Dcxr dicarbonyl and L-xylulose reductase decreases expression ISO Piroxicam results in decreased expression of DCXR mRNA CTD PMID:21858171 NCBI chr10:106,006,404...106,008,293 JBrowse link
G Ddb2 damage specific DNA binding protein 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of DDB2 mRNA CTD PMID:21858171 NCBI chr 3:77,185,114...77,207,650
Ensembl chr 3:77,185,109...77,207,631 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of DDIT3 mRNA] CTD PMID:21858171 NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201 		JBrowse link
G Ddx19a DEAD-box helicase 19A decreases expression ISO Piroxicam results in decreased expression of DDX19A mRNA CTD PMID:21858171 NCBI chr19:38,942,497...38,962,853
Ensembl chr19:38,942,496...38,962,854 		JBrowse link
G Ddx39a DExD-box helicase 39A decreases expression ISO Piroxicam results in decreased expression of DDX39A mRNA CTD PMID:21858171 NCBI chr19:24,418,743...24,427,422
Ensembl chr19:24,418,114...24,426,954 		JBrowse link
G Ddx3x DEAD-box helicase 3, X-linked decreases expression ISO Piroxicam results in decreased expression of DDX3X mRNA CTD PMID:21858171 NCBI chr  X:9,479,532...9,493,169
Ensembl chr  X:9,479,532...9,493,168 		JBrowse link
G Degs1 delta(4)-desaturase, sphingolipid 1 increases expression ISO Piroxicam results in increased expression of DEGS1 mRNA CTD PMID:21858171 NCBI chr13:93,946,154...93,953,677
Ensembl chr13:93,946,157...93,953,664 		JBrowse link
G Dffa DNA fragmentation factor subunit alpha decreases expression ISO Piroxicam results in decreased expression of DFFA mRNA CTD PMID:21858171 NCBI chr 5:159,540,715...159,553,639
Ensembl chr 5:159,540,715...159,553,633 		JBrowse link
G Dhfr dihydrofolate reductase decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of DHFR mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of DHFR mRNA]		 CTD PMID:21858171 NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713 		JBrowse link
G Dhx9 DExH-box helicase 9 decreases expression ISO Piroxicam results in decreased expression of DHX9 mRNA CTD PMID:21858171 NCBI chr13:65,602,322...65,639,098
Ensembl chr13:65,602,323...65,639,069 		JBrowse link
G Diaph1 diaphanous-related formin 1 decreases expression ISO Piroxicam results in decreased expression of DIAPH1 mRNA CTD PMID:21858171 NCBI chr18:29,669,659...29,769,070
Ensembl chr18:29,669,659...29,769,172 		JBrowse link
G Dlgap5 DLG associated protein 5 increases expression
multiple interactions		 ISO Piroxicam results in increased expression of DLGAP5 mRNA
Cisplatin inhibits the reaction [Piroxicam results in increased expression of DLGAP5 mRNA]		 CTD PMID:21858171 NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518 		JBrowse link
G Dnaja1 DnaJ heat shock protein family (Hsp40) member A1 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of DNAJA1 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of DNAJA1 mRNA]		 CTD PMID:21858171 NCBI chr 5:55,842,414...55,853,326
Ensembl chr 5:55,842,426...55,853,967 		JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 decreases expression ISO Piroxicam results in decreased expression of DNAJB1 mRNA CTD PMID:21858171 NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458 		JBrowse link
G Dnajb12 DnaJ heat shock protein family (Hsp40) member B12 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of DNAJB12 mRNA CTD PMID:21858171 NCBI chr20:27,828,216...27,846,428
Ensembl chr20:27,828,235...27,846,427 		JBrowse link
G Dnajb6 DnaJ heat shock protein family (Hsp40) member B6 decreases expression ISO Piroxicam results in decreased expression of DNAJB6 mRNA CTD PMID:21858171 NCBI chr 4:5,452,683...5,556,679
Ensembl chr 4:5,452,683...5,556,659 		JBrowse link
G Dnajc9 DnaJ heat shock protein family (Hsp40) member C9 multiple interactions
increases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of DNAJC9 mRNA] CTD PMID:21858171 NCBI chr15:3,923,842...3,928,118
Ensembl chr15:3,923,268...3,928,118 		JBrowse link
G Dnmt1 DNA methyltransferase 1 increases expression ISO Piroxicam results in increased expression of DNMT1 mRNA CTD PMID:21858171 NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659 		JBrowse link
G Donson DNA replication fork stabilization factor DONSON multiple interactions
increases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in increased expression of DONSON mRNA] CTD PMID:21858171 NCBI chr11:30,919,834...30,933,150
Ensembl chr11:30,923,239...30,932,889 		JBrowse link
G Dpm1 dolichyl-phosphate mannosyltransferase subunit 1, catalytic multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of DPM1 mRNA CTD PMID:21858171 NCBI chr 3:156,919,979...156,939,522
Ensembl chr 3:156,919,979...156,939,536 		JBrowse link
G Dpp3 dipeptidylpeptidase 3 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of DPP3 mRNA] CTD PMID:21858171 NCBI chr 1:202,204,683...202,228,501
Ensembl chr 1:202,204,693...202,228,541 		JBrowse link
G Dpyd dihydropyrimidine dehydrogenase multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of DPYD mRNA CTD PMID:21858171 NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982 		JBrowse link
G Dpysl2 dihydropyrimidinase-like 2 decreases expression ISO Piroxicam results in decreased expression of DPYSL2 mRNA CTD PMID:21858171 NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829 		JBrowse link
G Dtl denticleless E3 ubiquitin protein ligase homolog decreases expression ISO Piroxicam results in decreased expression of DTL mRNA CTD PMID:21858171 NCBI chr13:103,115,810...103,155,029
Ensembl chr13:103,117,186...103,154,890 		JBrowse link
G Dtymk deoxythymidylate kinase multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of DTYMK mRNA] CTD PMID:21858171 NCBI chr 9:94,315,552...94,324,386
Ensembl chr 9:94,315,552...94,324,870 		JBrowse link
G Dusp1 dual specificity phosphatase 1 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of DUSP1 mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of DUSP1 mRNA]		 CTD PMID:21858171 NCBI chr10:16,680,478...16,683,275 JBrowse link
G Dut deoxyuridine triphosphatase multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of DUT mRNA] CTD PMID:21858171 NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771 		JBrowse link
G Dync1h1 dynein cytoplasmic 1 heavy chain 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of DYNC1H1 mRNA CTD PMID:21858171 NCBI chr 6:129,615,208...129,680,888
Ensembl chr 6:129,609,397...129,680,883 		JBrowse link
G Ebna1bp2 EBNA1 binding protein 2 decreases expression ISO Piroxicam results in decreased expression of EBNA1BP2 mRNA CTD PMID:21858171 NCBI chr 5:132,148,164...132,152,730
Ensembl chr 5:132,148,143...132,153,267 		JBrowse link
G Ebp EBP, cholestenol delta-isomerase decreases expression ISO Piroxicam results in decreased expression of EBP mRNA CTD PMID:21858171 NCBI chr  X:14,299,427...14,305,826
Ensembl chr  X:14,299,448...14,305,826 		JBrowse link
G Ect2 epithelial cell transforming 2 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of ECT2 mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of ECT2 mRNA]		 CTD PMID:21858171 NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911 		JBrowse link
G Eef1e1 eukaryotic translation elongation factor 1 epsilon 1 decreases expression ISO Piroxicam results in decreased expression of EEF1E1 mRNA CTD PMID:21858171 NCBI chr17:26,148,652...26,159,358
Ensembl chr17:26,148,633...26,215,720 		JBrowse link
G Egfr epidermal growth factor receptor decreases expression
multiple interactions		 ISO
EXP		 Piroxicam results in decreased expression of EGFR mRNA
Piroxicam promotes the reaction [Hydrochloric Acid results in increased expression of EGFR protein]		 CTD PMID:15309881 PMID:21858171 NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382 		JBrowse link
G Eid1 EP300 interacting inhibitor of differentiation 1 decreases expression ISO Piroxicam results in decreased expression of EID1 mRNA CTD PMID:21858171 NCBI chr 3:112,922,961...112,924,680
Ensembl chr 3:112,922,668...112,924,752 		JBrowse link
G Eif1ax eukaryotic translation initiation factor 1A, X-linked multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of EIF1AX mRNA] CTD PMID:21858171 NCBI chr  X:35,498,698...35,513,402
Ensembl chr  X:35,498,517...35,513,335 		JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha decreases expression ISO Piroxicam results in decreased expression of EIF2S1 mRNA CTD PMID:21858171 NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225 		JBrowse link
G Eif3j eukaryotic translation initiation factor 3, subunit J decreases expression ISO Piroxicam results in decreased expression of EIF3J mRNA CTD PMID:21858171 NCBI chr 3:108,985,103...109,007,341
Ensembl chr 3:108,985,118...109,007,953 		JBrowse link
G Eif4a2 eukaryotic translation initiation factor 4A2 decreases expression ISO Piroxicam results in decreased expression of EIF4A2 mRNA CTD PMID:21858171 NCBI chr11:77,764,126...77,770,810
Ensembl chr11:77,764,124...77,770,781 		JBrowse link
G Eif4b eukaryotic translation initiation factor 4B multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of EIF4B mRNA CTD PMID:21858171 NCBI chr 7:133,206,637...133,228,436 JBrowse link
G Eif4e eukaryotic translation initiation factor 4E multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of EIF4E mRNA] CTD PMID:21858171 NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683 		JBrowse link
G Eif4e2 eukaryotic translation initiation factor 4E family member 2 decreases expression ISO Piroxicam results in decreased expression of EIF4E2 mRNA CTD PMID:21858171 NCBI chr 9:87,886,126...87,914,470
Ensembl chr 9:87,878,085...87,914,482 		JBrowse link
G Eif5 eukaryotic translation initiation factor 5 decreases expression ISO Piroxicam results in decreased expression of EIF5 mRNA CTD PMID:21858171 NCBI chr 6:130,589,162...130,597,656
Ensembl chr 6:130,589,143...130,597,656 		JBrowse link
G Eif5b eukaryotic translation initiation factor 5B multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of EIF5B mRNA] CTD PMID:21858171 NCBI chr 9:40,222,769...40,277,482
Ensembl chr 9:40,222,898...40,277,482 		JBrowse link
G Epas1 endothelial PAS domain protein 1 decreases expression ISO Piroxicam results in decreased expression of EPAS1 mRNA CTD PMID:21858171 NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228 		JBrowse link
G Epb41l2 erythrocyte membrane protein band 4.1-like 2 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of EPB41L2 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of EPB41L2 mRNA]		 CTD PMID:21858171 NCBI chr 1:19,863,010...20,037,795
Ensembl chr 1:19,863,009...20,037,721 		JBrowse link
G Esm1 endothelial cell-specific molecule 1 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ESM1 mRNA] CTD PMID:21858171 NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804 		JBrowse link
G Ewsr1 EWS RNA-binding protein 1 decreases expression ISO Piroxicam results in decreased expression of EWSR1 mRNA CTD PMID:21858171 NCBI chr14:79,965,365...79,994,108
Ensembl chr14:79,965,368...79,994,544 		JBrowse link
G Exoc3 exocyst complex component 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of EXOC3 mRNA CTD PMID:21858171 NCBI chr 1:29,091,298...29,122,056
Ensembl chr 1:29,091,294...29,122,045 		JBrowse link
G Exosc8 exosome component 8 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of EXOSC8 mRNA CTD PMID:21858171 NCBI chr 2:138,930,405...138,937,009
Ensembl chr 2:138,930,405...138,936,928 		JBrowse link
G Exosc9 exosome component 9 decreases expression ISO Piroxicam results in decreased expression of EXOSC9 mRNA CTD PMID:21858171 NCBI chr 2:119,416,028...119,426,981
Ensembl chr 2:119,388,715...119,427,051 		JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit decreases expression ISO Piroxicam results in decreased expression of EZH2 mRNA CTD PMID:21858171 NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362 		JBrowse link
G F8a1 coagulation factor VIII-associated 1 decreases expression ISO Piroxicam results in decreased expression of F8A1 mRNA CTD PMID:21858171 NCBI chr  X:150,957,357...150,958,871
Ensembl chr  X:150,916,679...150,960,168 		JBrowse link
G Fam111a FAM111 trypsin like peptidase A increases expression ISO Piroxicam results in increased expression of FAM111A mRNA CTD PMID:21858171 NCBI chr 1:209,640,865...209,656,551
Ensembl chr 1:209,640,953...209,656,547 		JBrowse link
G Fanci FA complementation group I increases expression ISO Piroxicam results in increased expression of FANCI mRNA CTD PMID:21858171 NCBI chr 1:133,327,264...133,383,661
Ensembl chr 1:133,327,297...133,383,640 		JBrowse link
G Fancl FA complementation group L increases expression ISO Piroxicam results in increased expression of FANCL mRNA CTD PMID:21858171 NCBI chr14:100,249,733...100,317,958
Ensembl chr14:100,248,875...100,314,255 		JBrowse link
G Fbxo9 f-box protein 9 multiple interactions
increases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of FBXO9 mRNA] CTD PMID:21858171 NCBI chr 8:78,958,482...78,984,015
Ensembl chr 8:78,958,483...78,983,949 		JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of FDFT1 mRNA] CTD PMID:21858171 NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287 		JBrowse link
G Fdps farnesyl diphosphate synthase decreases expression ISO Piroxicam results in decreased expression of FDPS mRNA CTD PMID:21858171 NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776 		JBrowse link
G Fdxr ferredoxin reductase multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of FDXR mRNA CTD PMID:21858171 NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658 		JBrowse link
G Fen1 flap structure-specific endonuclease 1 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of FEN1 mRNA] CTD PMID:21858171 NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003 		JBrowse link
G Fgf2 fibroblast growth factor 2 multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of FGF2 mRNA] CTD PMID:21858171 NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221 		JBrowse link
G Flii FLII, actin remodeling protein multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of FLII mRNA CTD PMID:21858171 NCBI chr10:45,394,032...45,408,051
Ensembl chr10:45,394,032...45,407,970 		JBrowse link
G Flnb filamin B decreases expression ISO Piroxicam results in decreased expression of FLNB mRNA CTD PMID:21858171 NCBI chr15:16,961,999...17,095,059
Ensembl chr15:16,962,003...17,095,006 		JBrowse link
G Foxm1 forkhead box M1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of FOXM1 mRNA CTD PMID:21858171 NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684 		JBrowse link
G Fst follistatin decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of FST mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of FST mRNA]		 CTD PMID:21858171 NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571 		JBrowse link
G Fut8 fucosyltransferase 8 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of FUT8 mRNA CTD PMID:21858171 NCBI chr 6:95,949,246...96,176,677
Ensembl chr 6:95,949,991...96,176,677 		JBrowse link
G Fyn FYN proto-oncogene, Src family tyrosine kinase decreases expression ISO Piroxicam results in decreased expression of FYN mRNA CTD PMID:21858171 NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911 		JBrowse link
G Gar1 GAR1 ribonucleoprotein decreases expression ISO Piroxicam results in decreased expression of GAR1 mRNA CTD PMID:21858171 NCBI chr 2:218,375,231...218,382,509
Ensembl chr 2:218,375,353...218,382,524 		JBrowse link
G Gbp1 guanylate binding protein 1 decreases expression ISO Piroxicam results in decreased expression of GBP1 mRNA CTD PMID:19192274 NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131
Ensembl chr 2:231,398,163...231,432,131 		JBrowse link
G Gcsh glycine cleavage system protein H decreases expression ISO Piroxicam results in decreased expression of GCSH mRNA CTD PMID:21858171 NCBI chr19:45,036,013...45,046,770
Ensembl chr19:45,036,011...45,046,792 		JBrowse link
G Gdf15 growth differentiation factor 15 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of GDF15 mRNA] CTD PMID:21858171 NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055 		JBrowse link
G Gins1 GINS complex subunit 1 multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of GINS1 mRNA] CTD PMID:21858171 NCBI chr 3:139,724,513...139,745,930
Ensembl chr 3:139,724,490...139,745,936 		JBrowse link
G Gins2 GINS complex subunit 2 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of GINS2 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of GINS2 mRNA]		 CTD PMID:21858171 NCBI chr19:48,626,770...48,639,523
Ensembl chr19:48,626,770...48,639,339 		JBrowse link
G Gins3 GINS complex subunit 3 increases expression ISO Piroxicam results in increased expression of GINS3 mRNA CTD PMID:21858171 NCBI chr19:9,420,085...9,428,621
Ensembl chr19:9,420,086...9,428,687 		JBrowse link
G Gla galactosidase, alpha decreases expression ISO Piroxicam results in decreased expression of GLA mRNA CTD PMID:21858171 NCBI chr  X:97,769,227...97,780,646
Ensembl chr  X:97,768,996...97,780,664 		JBrowse link
G Glipr1 GLI pathogenesis-related 1 decreases expression ISO Piroxicam results in decreased expression of GLIPR1 mRNA CTD PMID:21858171 NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429 		JBrowse link
G Gm2a ganglioside GM2 activator multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of GM2A mRNA CTD PMID:21858171 NCBI chr10:39,219,221...39,231,756
Ensembl chr10:39,219,243...39,231,757 		JBrowse link
G Gmnn geminin, DNA replication inhibitor decreases expression ISO Piroxicam results in decreased expression of GMNN mRNA CTD PMID:21858171 NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,301,808...40,310,054 		JBrowse link
G Gng11 G protein subunit gamma 11 decreases expression ISO Piroxicam results in decreased expression of GNG11 mRNA CTD PMID:21858171 NCBI chr 4:32,023,003...32,028,443
Ensembl chr 4:32,023,003...32,028,442 		JBrowse link
G Gpaa1 glycosylphosphatidylinositol anchor attachment 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of GPAA1 mRNA CTD PMID:21858171 NCBI chr 7:108,051,896...108,055,479
Ensembl chr 7:108,051,861...108,055,484 		JBrowse link
G Gpc1 glypican 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of GPC1 mRNA CTD PMID:21858171 NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047 		JBrowse link
G Grn granulin precursor multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of GRN mRNA] CTD PMID:21858171 NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775 		JBrowse link
G Gsdme gasdermin E decreases expression ISO Piroxicam results in decreased expression of GSDME mRNA CTD PMID:19192274 NCBI chr 4:79,258,799...79,321,129
Ensembl chr 4:79,257,804...79,320,806 		JBrowse link
G Gstt1 glutathione S-transferase theta 1 increases expression EXP Piroxicam results in increased expression of GSTT1 protein CTD PMID:9729437 NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585 		JBrowse link
G Gtf2ird1 GTF2I repeat domain containing 1 decreases expression ISO Piroxicam results in decreased expression of GTF2IRD1 mRNA CTD PMID:21858171 NCBI chr12:22,254,113...22,361,052
Ensembl chr12:22,254,221...22,361,040 		JBrowse link
G Gulp1 GULP PTB domain containing engulfment adaptor 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of GULP1 mRNA CTD PMID:21858171 NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005 		JBrowse link
G H2ax H2A.X variant histone decreases expression ISO Piroxicam results in decreased expression of H2AX mRNA CTD PMID:21858171 NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 		JBrowse link
G Hat1 histone acetyltransferase 1 decreases expression ISO Piroxicam results in decreased expression of HAT1 mRNA CTD PMID:21858171 NCBI chr 3:56,217,344...56,265,021
Ensembl chr 3:56,217,342...56,275,517 		JBrowse link
G Hexim1 HEXIM P-TEFb complex subunit 1 decreases expression ISO Piroxicam results in decreased expression of HEXIM1 mRNA CTD PMID:21858171 NCBI chr10:88,062,808...88,064,920
Ensembl chr10:88,062,803...88,066,189 		JBrowse link
G Hilpda hypoxia inducible lipid droplet-associated decreases expression ISO Piroxicam results in decreased expression of HILPDA mRNA CTD PMID:19192274 NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557 		JBrowse link
G Hmga2 high mobility group AT-hook 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HMGA2 mRNA CTD PMID:21858171 NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784 		JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase decreases expression ISO Piroxicam results in decreased expression of HMGCR mRNA CTD PMID:21858171 NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703 		JBrowse link
G Hmgn3 high mobility group nucleosomal binding domain 3 multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of HMGN3 mRNA] CTD PMID:21858171 NCBI chr 8:84,022,493...84,059,329
Ensembl chr 8:84,022,495...84,062,976 		JBrowse link
G Hmmr hyaluronan-mediated motility receptor multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HMMR mRNA CTD PMID:21858171 NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060 		JBrowse link
G Hnrnpa3 heterogeneous nuclear ribonucleoprotein A3 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of HNRNPA3 mRNA] CTD PMID:21858171 NCBI chr 3:60,578,574...60,588,755
Ensembl chr 3:60,578,673...60,588,306 		JBrowse link
G Hnrnpd heterogeneous nuclear ribonucleoprotein D multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of HNRNPD mRNA] CTD PMID:21858171 NCBI chr14:9,615,375...9,638,975
Ensembl chr14:9,615,479...9,633,786 		JBrowse link
G Hnrnpl heterogeneous nuclear ribonucleoprotein L multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HNRNPL mRNA CTD PMID:21858171 NCBI chr 1:84,098,558...84,111,568
Ensembl chr 1:84,100,879...84,111,553 		JBrowse link
G Hoxa9 homeobox A9 decreases expression ISO Piroxicam results in decreased expression of HOXA9 mRNA CTD PMID:21858171 NCBI chr 4:81,323,235...81,329,344
Ensembl chr 4:81,323,382...81,326,358 		JBrowse link
G Hs2st1 heparan sulfate 2-O-sulfotransferase 1 multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of HS2ST1 mRNA] CTD PMID:21858171 NCBI chr 2:233,508,018...233,641,769
Ensembl chr 2:233,508,021...233,641,769 		JBrowse link
G Hsbp1 heat shock factor binding protein 1 decreases expression ISO Piroxicam results in decreased expression of HSBP1 mRNA CTD PMID:21858171 NCBI chr19:47,401,039...47,405,373
Ensembl chr19:47,400,966...47,435,821 		JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 decreases expression ISO Piroxicam results in decreased expression of HSD11B1 mRNA CTD PMID:19192274 NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687 		JBrowse link
G Hsd17b11 hydroxysteroid (17-beta) dehydrogenase 11 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HSD17B11 mRNA CTD PMID:21858171 NCBI chr14:5,693,304...5,743,157
Ensembl chr14:5,711,964...5,743,161 		JBrowse link
G Hspa14 heat shock protein family A (Hsp70) member 14 increases expression
multiple interactions		 ISO Piroxicam results in increased expression of HSPA14 mRNA
Cisplatin inhibits the reaction [Piroxicam results in increased expression of HSPA14 mRNA]		 CTD PMID:21858171 NCBI chr17:74,728,945...74,749,727
Ensembl chr17:74,728,899...74,749,727 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of HSPA1A mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of HSPA1A mRNA]		 CTD PMID:21858171 NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227 		JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of HSPA1B mRNA] CTD PMID:21858171 NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240
Ensembl chr20:3,856,006...3,873,240 		JBrowse link
G Hspa4l heat shock protein family A (Hsp70) member 4 like multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HSPA4L mRNA CTD PMID:21858171 NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084 		JBrowse link
G Hspa9 heat shock protein family A (Hsp70) member 9 decreases expression ISO Piroxicam results in decreased expression of HSPA9 mRNA CTD PMID:21858171 NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292 		JBrowse link
G Hspe1 heat shock protein family E (Hsp10) member 1 multiple interactions
increases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of HSPE1 mRNA] CTD PMID:21858171 NCBI chr 9:56,589,912...56,593,000
Ensembl chr 9:56,589,789...56,593,089 		JBrowse link
G Hsph1 heat shock protein family H (Hsp110) member 1 decreases expression ISO Piroxicam results in decreased expression of HSPH1 mRNA CTD PMID:21858171 NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224 		JBrowse link
G Idh3a isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha decreases expression ISO Piroxicam results in decreased expression of IDH3A mRNA CTD PMID:21858171 NCBI chr 8:54,971,694...54,991,085
Ensembl chr 8:54,971,740...54,991,084 		JBrowse link
G Idi1 isopentenyl-diphosphate delta isomerase 1 decreases expression ISO Piroxicam results in decreased expression of IDI1 mRNA CTD PMID:21858171 NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357 		JBrowse link
G Ifi27 interferon, alpha-inducible protein 27 decreases expression ISO Piroxicam results in decreased expression of IFI27 mRNA CTD PMID:19192274 NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294 		JBrowse link
G Ifi44l interferon-induced protein 44-like decreases expression ISO Piroxicam results in decreased expression of IFI44L mRNA CTD PMID:19192274 NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359 		JBrowse link
G Il1rn interleukin 1 receptor antagonist decreases expression ISO Piroxicam results in decreased expression of IL1RN mRNA CTD PMID:19192274 NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445 		JBrowse link
G Il23a interleukin 23 subunit alpha decreases expression ISO Piroxicam results in decreased expression of IL23A mRNA CTD PMID:19192274 NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923 		JBrowse link
G Il6 interleukin 6 decreases expression ISO Piroxicam results in decreased expression of IL6 mRNA; Piroxicam results in decreased expression of IL6 protein CTD PMID:19192274 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Ilf3 interleukin enhancer binding factor 3 decreases expression ISO Piroxicam results in decreased expression of ILF3 mRNA CTD PMID:21858171 NCBI chr 8:19,922,409...19,960,495
Ensembl chr 8:19,922,460...19,960,350 		JBrowse link
G Insig1 insulin induced gene 1 multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of INSIG1 mRNA] CTD PMID:21858171 NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952 		JBrowse link
G Ipo7 importin 7 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of IPO7 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of IPO7 mRNA]		 CTD PMID:21858171 NCBI chr 1:164,062,702...164,102,938
Ensembl chr 1:164,062,702...164,102,938 		JBrowse link
G Iqcb1 IQ motif containing B1 decreases expression ISO Piroxicam results in decreased expression of IQCB1 mRNA CTD PMID:21858171 NCBI chr11:63,905,595...63,960,141
Ensembl chr11:63,905,590...63,960,093 		JBrowse link
G Irs2 insulin receptor substrate 2 decreases expression ISO Piroxicam results in decreased expression of IRS2 mRNA CTD PMID:21858171 NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482 		JBrowse link
G Isg15 ISG15 ubiquitin-like modifier decreases expression ISO Piroxicam results in decreased expression of ISG15 mRNA CTD PMID:19192274 NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435 		JBrowse link
G Isg20 interferon stimulated exonuclease gene 20 decreases expression ISO Piroxicam results in decreased expression of ISG20 mRNA CTD PMID:19192274 NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027 		JBrowse link
G Itgb3bp integrin subunit beta 3 binding protein decreases expression ISO Piroxicam results in decreased expression of ITGB3BP mRNA CTD PMID:21858171 NCBI chr 5:114,460,217...114,525,538
Ensembl chr 5:114,460,221...114,525,704 		JBrowse link
G Jag2 jagged canonical Notch ligand 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of JAG2 mRNA CTD PMID:21858171 NCBI chr 6:131,983,059...132,005,665
Ensembl chr 6:131,983,056...132,005,818 		JBrowse link
G Jmjd6 jumonji domain containing 6, arginine demethylase and lysine hydroxylase increases expression ISO Piroxicam results in increased expression of JMJD6 mRNA CTD PMID:21858171 NCBI chr10:102,041,131...102,047,182
Ensembl chr10:102,041,120...102,047,182 		JBrowse link
G Jund JunD proto-oncogene, AP-1 transcription factor subunit decreases expression ISO Piroxicam results in decreased expression of JUND mRNA CTD PMID:21858171 NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799 		JBrowse link
G Kcnma1 potassium calcium-activated channel subfamily M alpha 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of KCNMA1 mRNA CTD PMID:21858171 NCBI chr15:302,480...1,007,675
Ensembl chr15:302,214...1,001,198 		JBrowse link
G Kdelr2 KDEL endoplasmic reticulum protein retention receptor 2 decreases expression ISO Piroxicam results in decreased expression of KDELR2 mRNA CTD PMID:21858171 NCBI chr12:11,138,820...11,157,117
Ensembl chr12:11,138,820...11,157,153 		JBrowse link
G Kif11 kinesin family member 11 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of KIF11 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of KIF11 mRNA]		 CTD PMID:21858171 NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766 		JBrowse link
G Kif14 kinesin family member 14 multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of KIF14 mRNA] CTD PMID:21858171 NCBI chr13:47,926,975...47,990,598
Ensembl chr13:47,927,044...47,989,164 		JBrowse link
G Kif18a kinesin family member 18A decreases expression ISO Piroxicam results in decreased expression of KIF18A mRNA CTD PMID:21858171 NCBI chr 3:95,764,388...95,824,756
Ensembl chr 3:95,764,388...95,824,582 		JBrowse link
G Kif20a kinesin family member 20A multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of KIF20A mRNA] CTD PMID:21858171 NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780 		JBrowse link
G Kif23 kinesin family member 23 decreases expression ISO Piroxicam results in decreased expression of KIF23 mRNA CTD PMID:21858171 NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072 		JBrowse link
G Kif2c kinesin family member 2C increases expression ISO Piroxicam results in increased expression of KIF2C mRNA CTD PMID:21858171 NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637 		JBrowse link
G Kif4a kinesin family member 4A multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of KIF4A mRNA CTD PMID:21858171 NCBI chr  X:65,721,746...65,824,277
Ensembl chr  X:65,721,779...65,824,139 		JBrowse link
G Klf4 KLF transcription factor 4 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of KLF4 mRNA CTD PMID:21858171 NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602 		JBrowse link
G Klhl21 kelch-like family member 21 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of KLHL21 mRNA CTD PMID:21858171 NCBI chr 5:162,514,888...162,523,545
Ensembl chr 5:162,514,765...162,523,545 		JBrowse link
G Kpna1 karyopherin subunit alpha 1 decreases expression ISO Piroxicam results in decreased expression of KPNA1 mRNA CTD PMID:21858171 NCBI chr11:64,715,844...64,774,647
Ensembl chr11:64,717,563...64,774,623 		JBrowse link
G Kpna2 karyopherin subunit alpha 2 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of KPNA2 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of KPNA2 mRNA]		 CTD PMID:21858171 NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150 		JBrowse link
G Kpnb1 karyopherin subunit beta 1 multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of KPNB1 mRNA] CTD PMID:21858171 NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605 		JBrowse link
G Krr1 KRR1, small subunit processome component homolog increases expression ISO Piroxicam results in increased expression of KRR1 mRNA CTD PMID:21858171 NCBI chr 7:47,475,557...47,486,996
Ensembl chr 7:47,475,557...47,486,985 		JBrowse link
G Lamb3 laminin subunit beta 3 decreases expression ISO Piroxicam results in decreased expression of LAMB3 mRNA CTD PMID:19192274 NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405 		JBrowse link
G Lamc1 laminin subunit gamma 1 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of LAMC1 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of LAMC1 mRNA]		 CTD PMID:21858171 NCBI chr13:65,374,372...65,501,492
Ensembl chr13:65,374,372...65,501,492 		JBrowse link
G Lbr lamin B receptor multiple interactions
increases expression		 ISO Cisplatin affects the reaction [Piroxicam results in increased expression of LBR mRNA] CTD PMID:21858171 NCBI chr13:93,539,386...93,564,026
Ensembl chr13:93,538,920...93,564,017 		JBrowse link
G Ldlr low density lipoprotein receptor multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of LDLR mRNA] CTD PMID:21858171 NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580 		JBrowse link
G Lgals3bp galectin 3 binding protein multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of LGALS3BP mRNA CTD PMID:21858171 NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256 		JBrowse link
G Lhfpl2 LHFPL tetraspan subfamily member 2 increases expression ISO Piroxicam results in increased expression of LHFPL2 mRNA CTD PMID:21858171 NCBI chr 2:25,281,771...25,428,128
Ensembl chr 2:25,281,901...25,427,950 		JBrowse link
G Lrba LPS responsive beige-like anchor protein multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of LRBA mRNA CTD PMID:21858171 NCBI chr 2:171,623,668...172,202,576
Ensembl chr 2:171,621,507...172,202,724 		JBrowse link
G Lxn latexin increases expression ISO Piroxicam results in increased expression of LXN mRNA CTD PMID:19192274 NCBI chr 2:151,727,556...151,733,426
Ensembl chr 2:151,727,102...151,733,460 		JBrowse link
G Ly6e lymphocyte antigen 6 family member E decreases expression ISO Piroxicam results in decreased expression of LY6E mRNA CTD PMID:19192274 NCBI chr 7:106,935,530...106,939,689
Ensembl chr 7:106,935,761...106,939,689 		JBrowse link
G Mad2l1 mitotic arrest deficient 2 like 1 increases expression ISO Piroxicam results in increased expression of MAD2L1 mRNA CTD PMID:21858171 NCBI chr 4:95,906,692...95,918,885
Ensembl chr 4:95,906,817...95,913,470 		JBrowse link
G Magoh mago homolog, exon junction complex subunit increases expression ISO Piroxicam results in increased expression of MAGOH mRNA CTD PMID:21858171 NCBI chr 5:122,639,268...122,646,650
Ensembl chr 5:122,639,308...122,646,617 		JBrowse link
G Manf mesencephalic astrocyte-derived neurotrophic factor multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MANF mRNA] CTD PMID:21858171 NCBI chr 8:107,500,856...107,551,595
Ensembl chr 8:107,548,352...107,551,438 		JBrowse link
G Marcks myristoylated alanine rich protein kinase C substrate decreases expression ISO Piroxicam results in decreased expression of MARCKS mRNA CTD PMID:19192274 NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012 		JBrowse link
G Mars1 methionyl-tRNA synthetase 1 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MARS1 mRNA] CTD PMID:21858171 NCBI chr 7:63,121,142...63,138,550
Ensembl chr 7:63,121,142...63,138,495 		JBrowse link
G Mcam melanoma cell adhesion molecule decreases expression ISO Piroxicam results in decreased expression of MCAM mRNA CTD PMID:21858171 NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571 		JBrowse link
G Mcm3 minichromosome maintenance complex component 3 decreases expression ISO Piroxicam results in decreased expression of MCM3 mRNA CTD PMID:21858171 NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314 		JBrowse link
G Mcm4 minichromosome maintenance complex component 4 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of MCM4 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MCM4 mRNA]		 CTD PMID:21858171 NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144 		JBrowse link
G Mcm5 minichromosome maintenance complex component 5 increases expression ISO Piroxicam results in increased expression of MCM5 mRNA CTD PMID:21858171 NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389 		JBrowse link
G Mcm6 minichromosome maintenance complex component 6 decreases expression ISO Piroxicam results in decreased expression of MCM6 mRNA CTD PMID:21858171 NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960 		JBrowse link
G Mdk midkine increases expression ISO Piroxicam results in increased expression of MDK mRNA CTD PMID:21858171 NCBI chr 3:77,901,134...77,903,997
Ensembl chr 3:77,901,158...77,903,130 		JBrowse link
G Med21 mediator complex subunit 21 decreases expression ISO Piroxicam results in decreased expression of MED21 mRNA CTD PMID:21858171 NCBI chr 4:179,560,509...179,583,811
Ensembl chr 4:179,560,579...179,567,548 		JBrowse link
G Med27 mediator complex subunit 27 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of MED27 mRNA CTD PMID:21858171 NCBI chr 3:12,629,593...12,803,340
Ensembl chr 3:12,629,603...12,803,339 		JBrowse link
G Meis2 Meis homeobox 2 decreases expression ISO Piroxicam results in decreased expression of MEIS2 mRNA CTD PMID:21858171 NCBI chr 3:102,742,904...102,944,833
Ensembl chr 3:102,742,900...102,949,696 		JBrowse link
G Mest mesoderm specific transcript decreases expression ISO Piroxicam results in decreased expression of MEST mRNA CTD PMID:21858171 NCBI chr 4:59,354,445...59,364,919
Ensembl chr 4:59,354,447...59,366,145 		JBrowse link
G Met MET proto-oncogene, receptor tyrosine kinase decreases expression ISO Piroxicam results in decreased expression of MET mRNA CTD PMID:19192274 NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876 		JBrowse link
G Mgat2 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of MGAT2 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MGAT2 mRNA]		 CTD PMID:21858171 NCBI chr 6:87,656,360...87,658,849
Ensembl chr 6:87,656,349...87,658,177 		JBrowse link
G Mink1 misshapen-like kinase 1 multiple interactions
increases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of MINK1 mRNA] CTD PMID:21858171 NCBI chr10:55,278,293...55,330,782
Ensembl chr10:55,278,391...55,330,782 		JBrowse link
G Mis18a MIS18 kinetochore protein A multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of MIS18A mRNA] CTD PMID:21858171 NCBI chr11:29,968,030...29,981,058
Ensembl chr11:29,967,701...29,981,062 		JBrowse link
G Mki67 marker of proliferation Ki-67 decreases expression ISO Piroxicam results in decreased expression of MKI67 mRNA CTD PMID:21858171 NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762 		JBrowse link
G Mllt11 MLLT11, transcription factor 7 cofactor decreases expression ISO Piroxicam results in decreased expression of MLLT11 mRNA CTD PMID:21858171 NCBI chr 2:182,795,790...182,804,960
Ensembl chr 2:182,795,790...182,797,199 		JBrowse link
G Mmp10 matrix metallopeptidase 10 decreases expression ISO Piroxicam results in decreased expression of MMP10 mRNA CTD PMID:19192274 NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748 		JBrowse link
G Mmp2 matrix metallopeptidase 2 decreases activity ISO Piroxicam results in decreased activity of MMP2 protein CTD PMID:15990687 NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870 		JBrowse link
G Mob1a MOB kinase activator 1A decreases expression ISO Piroxicam results in decreased expression of MOB1A mRNA CTD PMID:21858171 NCBI chr 4:115,831,581...115,848,561
Ensembl chr 4:115,831,551...115,848,561 		JBrowse link
G Mpo myeloperoxidase decreases activity
increases activity
multiple interactions
increases expression		 EXP Piroxicam results in decreased activity of MPO
Piroxicam results in increased activity of MPO protein
pantoprazole inhibits the reaction [Piroxicam results in increased expression of MPO protein]		 CTD PMID:11996850 PMID:15309881 PMID:16080005 NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819 		JBrowse link
G Mr1 major histocompatibility complex, class I-related affects expression ISO Piroxicam affects the expression of MR1 mRNA CTD PMID:25811541 NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970 		JBrowse link
G Mrpl13 mitochondrial ribosomal protein L13 decreases expression ISO Piroxicam results in decreased expression of MRPL13 mRNA CTD PMID:21858171 NCBI chr 7:86,951,541...86,973,147
Ensembl chr 7:86,951,541...86,973,577 		JBrowse link
G Mrpl16 mitochondrial ribosomal protein L16 decreases expression ISO Piroxicam results in decreased expression of MRPL16 mRNA CTD PMID:21858171 NCBI chr 1:208,633,671...208,638,483
Ensembl chr 1:208,633,586...208,640,667 		JBrowse link
G Msh2 mutS homolog 2 decreases expression ISO Piroxicam results in decreased expression of MSH2 mRNA CTD PMID:21858171 NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938 		JBrowse link
G Msh6 mutS homolog 6 decreases expression ISO Piroxicam results in decreased expression of MSH6 mRNA CTD PMID:21858171 NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956 		JBrowse link
G Msmo1 methylsterol monooxygenase 1 decreases expression ISO Piroxicam results in decreased expression of MSMO1 mRNA CTD PMID:21858171 NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016 		JBrowse link
G Mt2A metallothionein 2A decreases expression ISO Piroxicam results in decreased expression of MT2A mRNA CTD PMID:21858171 NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784 		JBrowse link
G Mx1 MX dynamin like GTPase 1 decreases expression ISO Piroxicam results in decreased expression of MX1 mRNA CTD PMID:19192274 NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions EXP Piroxicam inhibits the reaction [Azoxymethane results in increased expression of MYC mRNA]; Piroxicam inhibits the reaction [Azoxymethane results in increased expression of MYC protein] CTD PMID:12189186 NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630 		JBrowse link
G Mycbp Myc binding protein multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MYCBP mRNA] CTD PMID:21858171 NCBI chr 5:136,135,955...136,143,163
Ensembl chr 5:136,135,931...136,145,616 		JBrowse link
G Naa15 N(alpha)-acetyltransferase 15, NatA auxiliary subunit increases expression ISO Piroxicam results in increased expression of NAA15 mRNA CTD PMID:21858171 NCBI chr 2:135,458,018...135,520,756
Ensembl chr 2:135,457,948...135,520,756 		JBrowse link
G Nab1 Ngfi-A binding protein 1 decreases expression ISO Piroxicam results in decreased expression of NAB1 mRNA CTD PMID:21858171 NCBI chr 9:49,053,579...49,093,078
Ensembl chr 9:49,053,758...49,092,098 		JBrowse link
G Nap1l1 nucleosome assembly protein 1-like 1 increases expression ISO Piroxicam results in increased expression of NAP1L1 mRNA CTD PMID:21858171 NCBI chr 7:46,933,278...46,957,853
Ensembl chr 7:46,933,356...46,956,593 		JBrowse link
G Nasp nuclear autoantigenic sperm protein decreases expression ISO Piroxicam results in decreased expression of NASP mRNA CTD PMID:21858171 NCBI chr 5:130,057,363...130,083,003
Ensembl chr 5:130,057,363...130,082,928 		JBrowse link
G Nbr1 NBR1, autophagy cargo receptor multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of NBR1 mRNA] CTD PMID:21858171 NCBI chr10:86,477,775...86,506,418
Ensembl chr10:86,478,290...86,506,412 		JBrowse link
G Ncapd3 non-SMC condensin II complex, subunit D3 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of NCAPD3 mRNA] CTD PMID:21858171 NCBI chr 8:25,437,067...25,506,375
Ensembl chr 8:25,437,123...25,506,373 		JBrowse link
G Ncapg non-SMC condensin I complex, subunit G decreases expression ISO Piroxicam results in decreased expression of NCAPG mRNA CTD PMID:21858171 NCBI chr14:65,403,930...65,432,902
Ensembl chr14:65,404,163...65,432,902 		JBrowse link
G Ncaph non-SMC condensin I complex, subunit H multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of NCAPH mRNA] CTD PMID:21858171 NCBI chr 3:114,371,937...114,399,178
Ensembl chr 3:114,371,941...114,399,180 		JBrowse link
G Nck1 NCK adaptor protein 1 decreases expression ISO Piroxicam results in decreased expression of NCK1 mRNA CTD PMID:21858171 NCBI chr 8:101,018,610...101,079,237
Ensembl chr 8:101,018,702...101,079,300 		JBrowse link
G Ndc80 NDC80 kinetochore complex component multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of NDC80 mRNA] CTD PMID:21858171 NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924 		JBrowse link
G Ndufa4l2 NDUFA4, mitochondrial complex associated like 2 decreases expression ISO Piroxicam results in decreased expression of NDUFA4L2 mRNA CTD PMID:19192274 NCBI chr 7:63,351,021...63,359,010
Ensembl chr 7:63,356,883...63,359,010 		JBrowse link
G Ndufa5 NADH:ubiquinone oxidoreductase subunit A5 decreases expression ISO Piroxicam results in decreased expression of NDUFA5 mRNA CTD PMID:21858171 NCBI chr 4:52,997,327...53,005,685
Ensembl chr 4:52,995,546...53,005,598 		JBrowse link
G Nek9 NIMA-related kinase 9 increases expression ISO Piroxicam results in increased expression of NEK9 mRNA CTD PMID:21858171 NCBI chr 6:104,944,056...104,984,538
Ensembl chr 6:104,944,056...104,984,538 		JBrowse link
G Net1 neuroepithelial cell transforming 1 decreases expression ISO Piroxicam results in decreased expression of NET1 mRNA CTD PMID:21858171 NCBI chr17:66,341,251...66,370,445
Ensembl chr17:66,340,728...66,370,441 		JBrowse link
G Nfatc3 nuclear factor of activated T-cells 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of NFATC3 mRNA CTD PMID:21858171 NCBI chr19:33,960,643...34,035,150
Ensembl chr19:33,960,852...34,035,150 		JBrowse link
G Nfe2l1 NFE2 like bZIP transcription factor 1 multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of NFE2L1 mRNA] CTD PMID:21858171 NCBI chr10:81,796,055...81,812,926
Ensembl chr10:81,800,366...81,832,318 		JBrowse link
G Niban1 niban apoptosis regulator 1 decreases expression ISO Piroxicam results in decreased expression of NIBAN1 mRNA CTD PMID:21858171 NCBI chr13:63,674,240...63,827,748
Ensembl chr13:63,674,171...63,827,729 		JBrowse link
G Nid2 nidogen 2 increases expression ISO Piroxicam results in increased expression of NID2 mRNA CTD PMID:19192274 NCBI chr15:4,458,082...4,513,808
Ensembl chr15:4,458,084...4,513,843 		JBrowse link
G Nisch nischarin multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of NISCH mRNA CTD PMID:21858171 NCBI chr16:6,364,370...6,400,675
Ensembl chr16:6,364,374...6,400,668 		JBrowse link
G Nkx3-1 NK3 homeobox 1 multiple interactions ISO Piroxicam inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA] CTD PMID:10537180 NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441 		JBrowse link
G Nle1 notchless homolog 1 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of NLE1 mRNA] CTD PMID:21858171 NCBI chr10:67,834,059...67,844,771
Ensembl chr10:67,834,062...67,842,658 		JBrowse link
G Nme7 NME/NM23 family member 7 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of NME7 mRNA CTD PMID:21858171 NCBI chr13:76,657,303...76,786,768
Ensembl chr13:76,657,367...76,786,765 		JBrowse link
G Nmt2 N-myristoyltransferase 2 decreases expression ISO Piroxicam results in decreased expression of NMT2 mRNA CTD PMID:21858171 NCBI chr17:74,917,833...74,964,788
Ensembl chr17:74,917,833...74,961,080 		JBrowse link
G Nol8 nucleolar protein 8 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of NOL8 mRNA CTD PMID:21858171 NCBI chr17:14,990,394...15,013,784
Ensembl chr17:14,990,417...15,013,848 		JBrowse link
G Nolc1 nucleolar and coiled-body phosphoprotein 1 increases expression ISO Piroxicam results in increased expression of NOLC1 mRNA CTD PMID:21858171 NCBI chr 1:244,921,275...244,932,089
Ensembl chr 1:244,921,377...244,932,088 		JBrowse link
G Npdc1 neural proliferation, differentiation and control, 1 decreases expression ISO Piroxicam results in decreased expression of NPDC1 mRNA CTD PMID:21858171 NCBI chr 3:8,220,446...8,226,446
Ensembl chr 3:8,213,663...8,226,866 		JBrowse link
G Nr4a3 nuclear receptor subfamily 4, group A, member 3 decreases expression ISO Piroxicam results in decreased expression of NR4A3 mRNA CTD PMID:19192274 NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733 		JBrowse link
G Nrip1 nuclear receptor interacting protein 1 decreases expression ISO Piroxicam results in decreased expression of NRIP1 mRNA CTD PMID:21858171 NCBI chr11:14,895,843...14,979,490
Ensembl chr11:14,895,553...14,981,761 		JBrowse link
G Nrp1 neuropilin 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of NRP1 mRNA CTD PMID:21858171 NCBI chr19:56,359,455...56,514,628
Ensembl chr19:56,359,455...56,513,633 		JBrowse link
G Nsl1 NSL1 component of MIS12 kinetochore complex decreases expression ISO Piroxicam results in decreased expression of NSL1 mRNA CTD PMID:21858171 NCBI chr13:102,649,050...102,674,059
Ensembl chr13:102,649,058...102,674,054 		JBrowse link
G Nudt21 nudix hydrolase 21 decreases expression ISO Piroxicam results in decreased expression of NUDT21 mRNA CTD PMID:21858171 NCBI chr19:10,974,800...10,993,841
Ensembl chr19:10,974,241...10,991,682 		JBrowse link
G Nup160 nucleoporin 160 decreases expression ISO Piroxicam results in decreased expression of NUP160 mRNA CTD PMID:21858171 NCBI chr 3:76,665,786...76,729,296
Ensembl chr 3:76,665,786...76,724,565 		JBrowse link
G Nup50 nucleoporin 50 decreases expression ISO Piroxicam results in decreased expression of NUP50 mRNA CTD PMID:21858171 NCBI chr 7:116,047,960...116,065,231
Ensembl chr 7:116,048,021...116,066,905 		JBrowse link
G Nup85 nucleoporin 85 decreases expression ISO Piroxicam results in decreased expression of NUP85 mRNA CTD PMID:21858171 NCBI chr10:100,806,482...100,825,029
Ensembl chr10:100,806,437...100,825,043 		JBrowse link
G Nup88 nucleoporin 88 decreases expression ISO Piroxicam results in decreased expression of NUP88 mRNA CTD PMID:21858171 NCBI chr10:55,667,903...55,692,249
Ensembl chr10:55,667,906...55,692,257 		JBrowse link
G Nxt2 nuclear transport factor 2-like export factor 2 increases expression ISO Piroxicam results in increased expression of NXT2 mRNA CTD PMID:21858171 NCBI chr  X:105,855,616...105,862,902
Ensembl chr  X:105,855,608...105,862,899 		JBrowse link
G Ogt O-linked N-acetylglucosamine (GlcNAc) transferase multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of OGT mRNA] CTD PMID:21858171 NCBI chr  X:66,771,278...66,816,148
Ensembl chr  X:66,771,349...66,816,146 		JBrowse link
G Olfml2b olfactomedin-like 2B increases expression ISO Piroxicam results in increased expression of OLFML2B mRNA CTD PMID:19192274 NCBI chr13:82,869,414...82,906,607
Ensembl chr13:82,869,433...82,906,607 		JBrowse link
G Opa1 OPA1, mitochondrial dynamin like GTPase decreases expression ISO Piroxicam results in decreased expression of OPA1 mRNA CTD PMID:21858171 NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109 		JBrowse link
G Optn optineurin decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of OPTN mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of OPTN mRNA]		 CTD PMID:21858171 NCBI chr17:73,209,572...73,260,251
Ensembl chr17:73,209,575...73,260,251 		JBrowse link
G Orc6 origin recognition complex, subunit 6 decreases expression ISO Piroxicam results in decreased expression of ORC6 mRNA CTD PMID:21858171 NCBI chr19:21,757,867...21,765,638
Ensembl chr19:21,757,866...21,765,662 		JBrowse link
G Pa2g4 proliferation-associated 2G4 increases expression ISO Piroxicam results in increased expression of PA2G4 mRNA CTD PMID:21858171 NCBI chr 7:984,795...992,264
Ensembl chr 7:983,971...992,331 		JBrowse link
G Pacsin2 protein kinase C and casein kinase substrate in neurons 2 increases expression ISO Piroxicam results in increased expression of PACSIN2 mRNA CTD PMID:21858171 NCBI chr 7:114,505,525...114,599,087
Ensembl chr 7:114,505,152...114,598,546 		JBrowse link
G Pafah1b1 platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of PAFAH1B1 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of PAFAH1B1 mRNA]		 CTD PMID:21858171 NCBI chr10:59,533,042...59,591,808
Ensembl chr10:59,534,117...59,591,808 		JBrowse link
G Palld palladin, cytoskeletal associated protein decreases expression ISO Piroxicam results in decreased expression of PALLD mRNA CTD PMID:21858171 NCBI chr16:28,228,006...28,621,349
Ensembl chr16:27,981,354...28,621,337 		JBrowse link
G Pank2 pantothenate kinase 2 increases expression ISO Piroxicam results in increased expression of PANK2 mRNA CTD PMID:21858171 NCBI chr 3:118,483,382...118,519,551
Ensembl chr 3:118,483,444...118,518,320 		JBrowse link
G Paxip1 PAX interacting protein 1 decreases expression ISO Piroxicam results in decreased expression of PAXIP1 mRNA CTD PMID:21858171 NCBI chr 4:7,525,132...7,576,659
Ensembl chr 4:7,525,004...7,576,548 		JBrowse link
G Pbk PDZ binding kinase decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of PBK mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of PBK mRNA]		 CTD PMID:21858171 NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014 		JBrowse link
G Pbx1 PBX homeobox 1 increases expression ISO Piroxicam results in increased expression of PBX1 mRNA CTD PMID:21858171 NCBI chr13:80,278,766...80,588,563
Ensembl chr13:80,278,770...80,588,594 		JBrowse link
G Pcgf2 polycomb group ring finger 2 increases expression ISO Piroxicam results in increased expression of PCGF2 mRNA CTD PMID:21858171 NCBI chr10:82,682,563...82,694,563
Ensembl chr10:82,683,553...82,693,406 		JBrowse link
G Pclaf PCNA clamp associated factor decreases expression ISO Piroxicam results in decreased expression of PCLAF mRNA CTD PMID:21858171 NCBI chr 8:66,420,606...66,432,994
Ensembl chr 8:66,420,587...66,432,994
Ensembl chr 8:66,420,587...66,432,994 		JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression ISO Piroxicam results in decreased expression of PCNA mRNA CTD PMID:21858171 NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995 		JBrowse link
G Pdss1 decaprenyl diphosphate synthase subunit 1 multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of PDSS1 mRNA] CTD PMID:21858171 NCBI chr17:85,059,953...85,098,739
Ensembl chr17:85,060,106...85,098,730 		JBrowse link
G Pgls 6-phosphogluconolactonase increases expression ISO Piroxicam results in increased expression of PGLS mRNA CTD PMID:21858171 NCBI chr16:18,300,317...18,305,803
Ensembl chr16:18,300,317...18,305,803 		JBrowse link
G Pgrmc2 progesterone receptor membrane component 2 multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of PGRMC2 mRNA] CTD PMID:21858171 NCBI chr 2:124,068,257...124,084,155
Ensembl chr 2:124,068,260...124,084,155 		JBrowse link
G Phb1 prohibitin 1 decreases expression ISO Piroxicam results in decreased expression of PHB1 mRNA CTD PMID:21858171 NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042 		JBrowse link
G Phgdh phosphoglycerate dehydrogenase multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of PHGDH mRNA] CTD PMID:21858171 NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944 		JBrowse link
G Phip pleckstrin homology domain interacting protein increases expression ISO Piroxicam results in increased expression of PHIP mRNA CTD PMID:21858171 NCBI chr 8:83,776,802...83,891,192
Ensembl chr 8:83,781,465...83,894,283 		JBrowse link
G Phlda2 pleckstrin homology-like domain, family A, member 2 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of PHLDA2 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of PHLDA2 mRNA]		 CTD PMID:21858171 NCBI chr 1:198,696,897...198,699,292
Ensembl chr 1:198,696,897...198,697,836 		JBrowse link
G Pigp phosphatidylinositol glycan anchor biosynthesis, class P decreases expression ISO Piroxicam results in decreased expression of PIGP mRNA CTD PMID:21858171 NCBI chr11:33,682,943...33,689,111
Ensembl chr11:33,682,948...33,689,321 		JBrowse link
G Pik3r4 phosphoinositide-3-kinase, regulatory subunit 4 decreases expression ISO Piroxicam results in decreased expression of PIK3R4 mRNA CTD PMID:21858171 NCBI chr 8:106,267,908...106,316,585
Ensembl chr 8:106,267,954...106,316,584 		JBrowse link
G Pilra paired immunoglobin-like type 2 receptor alpha decreases expression ISO Piroxicam results in decreased expression of PILRA mRNA CTD PMID:19192274 NCBI chr12:17,787,169...17,798,149
Ensembl chr12:17,787,127...17,798,094 		JBrowse link
G Pink1 PTEN induced kinase 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of PINK1 mRNA CTD PMID:21858171 NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635 		JBrowse link
G Plat plasminogen activator, tissue type decreases expression ISO Piroxicam results in decreased expression of PLAT mRNA CTD PMID:21858171 NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223 		JBrowse link
G Plaur plasminogen activator, urokinase receptor decreases expression ISO Piroxicam results in decreased expression of PLAUR mRNA CTD PMID:21858171 NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595 		JBrowse link
G Plk4 polo-like kinase 4 multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of PLK4 mRNA] CTD PMID:21858171 NCBI chr 2:123,802,527...123,820,942
Ensembl chr 2:123,802,512...123,820,942 		JBrowse link
G Plpp3 phospholipid phosphatase 3 decreases expression ISO Piroxicam results in decreased expression of PLPP3 mRNA CTD PMID:19192274 NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205 		JBrowse link
G Pls1 plastin 1 multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of PLS1 mRNA] CTD PMID:21858171 NCBI chr 8:96,316,703...96,426,592
Ensembl chr 8:96,317,849...96,385,195 		JBrowse link
G Plxnb2 plexin B2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of PLXNB2 mRNA CTD PMID:21858171 NCBI chr 7:120,232,276...120,258,385
Ensembl chr 7:120,232,331...120,258,330 		JBrowse link
G Pnn pinin, desmosome associated protein multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of PNN mRNA] CTD PMID:21858171 NCBI chr 6:76,758,138...76,766,451
Ensembl chr 6:76,758,117...76,766,889 		JBrowse link
G Pold3 DNA polymerase delta 3, accessory subunit decreases expression ISO Piroxicam results in decreased expression of POLD3 mRNA CTD PMID:21858171 NCBI chr 1:154,417,893...154,456,687
Ensembl chr 1:154,418,084...154,456,665 		JBrowse link
G Pole2 DNA polymerase epsilon 2, accessory subunit increases expression
multiple interactions		 ISO Piroxicam results in increased expression of POLE2 mRNA
Cisplatin inhibits the reaction [Piroxicam results in increased expression of POLE2 mRNA]		 CTD PMID:21858171 NCBI chr 6:87,674,702...87,712,723
Ensembl chr 6:87,674,702...87,699,305 		JBrowse link
G Pole3 DNA polymerase epsilon 3, accessory subunit decreases expression ISO Piroxicam results in decreased expression of POLE3 mRNA CTD PMID:21858171 NCBI chr 5:75,973,941...75,977,175
Ensembl chr 5:75,974,717...75,977,231
Ensembl chr 7:75,974,717...75,977,231 		JBrowse link
G Polr3k RNA polymerase III subunit K decreases expression ISO Piroxicam results in decreased expression of POLR3K mRNA CTD PMID:21858171 NCBI chr 3:168,982,846...168,987,043
Ensembl chr 3:168,982,812...168,987,040 		JBrowse link
G Pop7 POP7 homolog, ribonuclease P/MRP subunit decreases expression ISO Piroxicam results in decreased expression of POP7 mRNA CTD PMID:21858171 NCBI chr12:19,189,384...19,190,425
Ensembl chr12:19,189,138...19,190,674 		JBrowse link
G Ppm1b protein phosphatase, Mg2+/Mn2+ dependent, 1B multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of PPM1B mRNA CTD PMID:21858171 NCBI chr 6:9,646,695...9,707,471
Ensembl chr 6:9,655,765...9,707,974 		JBrowse link
G Ppp1cb protein phosphatase 1 catalytic subunit beta decreases expression ISO Piroxicam results in decreased expression of PPP1CB mRNA CTD PMID:21858171 NCBI chr 6:23,958,813...23,992,841
Ensembl chr 6:23,960,998...23,992,824 		JBrowse link
G Ppp1r15a protein phosphatase 1, regulatory subunit 15A multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of PPP1R15A mRNA] CTD PMID:21858171 NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171 		JBrowse link
G Ppp2r1b protein phosphatase 2 scaffold subunit A beta decreases expression ISO Piroxicam results in decreased expression of PPP2R1B mRNA CTD PMID:21858171 NCBI chr 8:51,195,860...51,228,442
Ensembl chr 8:51,186,717...51,228,485 		JBrowse link
G Ppp3ca protein phosphatase 3 catalytic subunit alpha multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of PPP3CA mRNA CTD PMID:21858171 NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974 		JBrowse link
G Ppp4r2 protein phosphatase 4, regulatory subunit 2 increases expression ISO Piroxicam results in increased expression of PPP4R2 mRNA CTD PMID:19192274 NCBI chr 4:133,454,555...133,495,486
Ensembl chr 4:133,454,555...133,495,486 		JBrowse link
G Prc1 protein regulator of cytokinesis 1 decreases expression ISO Piroxicam results in decreased expression of PRC1 mRNA CTD PMID:21858171 NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765 		JBrowse link
G Prdm4 PR/SET domain 4 decreases expression ISO Piroxicam results in decreased expression of PRDM4 mRNA CTD PMID:21858171 NCBI chr 7:17,953,832...17,980,489
Ensembl chr 7:17,954,019...17,980,489 		JBrowse link
G Prkacb protein kinase cAMP-activated catalytic subunit beta decreases expression ISO Piroxicam results in decreased expression of PRKACB mRNA CTD PMID:21858171 NCBI chr 2:235,636,878...235,726,928
Ensembl chr 2:235,636,885...235,726,198 		JBrowse link
G Prpf18 pre-mRNA processing factor 18 decreases expression ISO Piroxicam results in decreased expression of PRPF18 mRNA CTD PMID:21858171 NCBI chr17:73,630,560...73,661,210
Ensembl chr17:73,630,571...73,690,979 		JBrowse link
G Prpf4b pre-mRNA processing factor 4B decreases expression ISO Piroxicam results in decreased expression of PRP4K mRNA CTD PMID:21858171 NCBI chr17:29,985,343...30,020,285
Ensembl chr17:29,985,343...30,019,625 		JBrowse link
G Prps1 phosphoribosyl pyrophosphate synthetase 1 decreases expression ISO Piroxicam results in decreased expression of PRPS1 mRNA CTD PMID:21858171 NCBI chr  X:104,132,139...104,154,191
Ensembl chr  X:104,132,141...104,154,187 		JBrowse link
G Psap prosaposin multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of PSAP mRNA] CTD PMID:21858171 NCBI chr20:28,214,229...28,240,501
Ensembl chr20:28,214,271...28,240,498 		JBrowse link
G Psat1 phosphoserine aminotransferase 1 decreases expression ISO Piroxicam results in decreased expression of PSAT1 mRNA CTD PMID:21858171 NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682 		JBrowse link
G Psma2 proteasome 20S subunit alpha 2 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of PSMA2 mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of PSMA2 mRNA]		 CTD PMID:21858171 NCBI chr17:50,554,536...50,564,923
Ensembl chr17:50,551,924...50,564,938 		JBrowse link
G Psmc2 proteasome 26S subunit, ATPase 2 decreases expression ISO Piroxicam results in decreased expression of PSMC2 mRNA CTD PMID:21858171 NCBI chr 4:13,255,850...13,270,160
Ensembl chr 4:13,255,856...13,270,185 		JBrowse link
G Psmc3ip PSMC3 interacting protein increases expression ISO Piroxicam results in increased expression of PSMC3IP mRNA CTD PMID:21858171 NCBI chr10:86,024,281...86,027,928
Ensembl chr10:86,023,950...86,027,423 		JBrowse link
G Psmd12 proteasome 26S subunit, non-ATPase 12 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of PSMD12 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of PSMD12 mRNA]		 CTD PMID:21858171 NCBI chr10:92,438,223...92,457,323
Ensembl chr10:92,438,298...92,457,287 		JBrowse link
G Ptger4 prostaglandin E receptor 4 decreases expression ISO Piroxicam results in decreased expression of PTGER4 mRNA CTD PMID:21858171 NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670 		JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Piroxicam results in decreased activity of PTGS1 protein CTD PMID:9258749 NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
decreases activity
decreases expression		 ISO
EXP		 Piroxicam inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]
Piroxicam binds to and results in decreased activity of PTGS2 protein; Piroxicam inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]
[Hydrochloric Acid co-treated with Piroxicam] results in increased expression of PTGS2 mRNA; Piroxicam promotes the reaction [L 748706 results in decreased activity of PTGS2 protein]
Piroxicam results in decreased activity of PTGS2 protein
Piroxicam results in decreased expression of PTGS2 mRNA		 CTD PMID:9258749 PMID:12925531 PMID:15309881 PMID:15878914 PMID:19147701 More... NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Ptp4a1 protein tyrosine phosphatase 4A1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of PTP4A1 mRNA CTD PMID:21858171 NCBI chr 9:33,214,201...33,245,046
Ensembl chr 9:33,214,208...33,221,964 		JBrowse link
G Ptp4a2 protein tyrosine phosphatase 4A2 multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of PTP4A2 mRNA] CTD PMID:21858171 NCBI chr 5:142,165,405...142,192,412
Ensembl chr 5:142,165,700...142,191,899 		JBrowse link
G Ptx3 pentraxin 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of PTX3 mRNA CTD PMID:21858171 NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323 		JBrowse link
G Rab1a RAB1A, member RAS oncogene family decreases expression ISO Piroxicam results in decreased expression of RAB1A mRNA CTD PMID:21858171 NCBI chr14:94,422,219...94,448,799
Ensembl chr14:94,415,275...94,448,248 		JBrowse link
G Rab2a RAB2A, member RAS oncogene family multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of RAB2A mRNA CTD PMID:21858171 NCBI chr 5:21,676,017...21,740,035
Ensembl chr 5:21,676,129...21,739,899 		JBrowse link
G Rab7a RAB7A, member RAS oncogene family multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of RAB7A mRNA CTD PMID:21858171 NCBI chr 4:120,461,966...120,510,756
Ensembl chr 4:120,461,963...120,506,889 		JBrowse link
G Rab8a RAB8A, member RAS oncogene family increases expression ISO Piroxicam results in increased expression of RAB8A mRNA CTD PMID:21858171 NCBI chr16:17,654,027...17,675,385
Ensembl chr16:17,654,034...17,675,678 		JBrowse link
G Rabep1 rabaptin, RAB GTPase binding effector protein 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of RABEP1 mRNA CTD PMID:21858171 NCBI chr10:55,566,156...55,667,595
Ensembl chr10:55,566,185...55,665,973 		JBrowse link
G Racgap1 Rac GTPase-activating protein 1 multiple interactions
increases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of RACGAP1 mRNA] CTD PMID:21858171 NCBI chr 7:130,750,936...130,780,891
Ensembl chr 7:130,750,936...130,780,831 		JBrowse link
G Rad1 RAD1 checkpoint DNA exonuclease decreases expression ISO Piroxicam results in decreased expression of RAD1 mRNA CTD PMID:21858171 NCBI chr 2:59,461,597...59,469,707
Ensembl chr 2:59,461,607...59,469,689 		JBrowse link
G Rad17 RAD17 checkpoint clamp loader component increases expression ISO Piroxicam results in increased expression of RAD17 mRNA CTD PMID:21858171 NCBI chr 2:31,764,260...31,794,542
Ensembl chr 2:31,764,261...31,794,072 		JBrowse link
G Rad50 RAD50 double strand break repair protein multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of RAD50 mRNA] CTD PMID:21858171 NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396 		JBrowse link
G Rad51ap1 RAD51 associated protein 1 decreases expression ISO Piroxicam results in decreased expression of RAD51AP1 mRNA CTD PMID:21858171 NCBI chr 4:159,759,454...159,772,473
Ensembl chr 4:159,759,459...159,772,524 		JBrowse link
G Ranbp1 RAN binding protein 1 decreases expression ISO Piroxicam results in decreased expression of RANBP1 mRNA CTD PMID:21858171 NCBI chr11:82,742,603...82,750,836
Ensembl chr11:82,742,600...82,750,838 		JBrowse link
G Ranbp2 RAN binding protein 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of RANBP2 mRNA CTD PMID:21858171 NCBI chr20:26,442,156...26,493,481
Ensembl chr20:26,442,217...26,493,481 		JBrowse link
G Rb1 RB transcriptional corepressor 1 decreases expression ISO Piroxicam results in decreased expression of RB1 mRNA CTD PMID:21858171 NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302 		JBrowse link
G Rbbp4 RB binding protein 4, chromatin remodeling factor decreases expression ISO Piroxicam results in decreased expression of RBBP4 mRNA CTD PMID:21858171 NCBI chr 5:141,655,863...141,675,157
Ensembl chr 5:141,638,421...141,675,284 		JBrowse link
G Rbm25 RNA binding motif protein 25 multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of RBM25 mRNA] CTD PMID:21858171 NCBI chr 6:103,271,775...103,319,090
Ensembl chr 6:103,271,801...103,317,854 		JBrowse link
G Rbx1 ring-box 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of RBX1 mRNA CTD PMID:21858171 NCBI chr 7:112,976,863...113,001,051
Ensembl chr 7:112,990,835...113,001,051 		JBrowse link
G Rdh11 retinol dehydrogenase 11 multiple interactions ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of RDH11 mRNA] CTD PMID:21858171 NCBI chr 6:97,979,377...97,995,252
Ensembl chr 6:97,979,378...97,995,252 		JBrowse link
G Recql RecQ like helicase decreases expression ISO Piroxicam results in decreased expression of RECQL mRNA CTD PMID:21858171 NCBI chr 4:175,308,337...175,332,965
Ensembl chr 4:175,304,117...175,332,945 		JBrowse link
G Reep5 receptor accessory protein 5 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of REEP5 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of REEP5 mRNA]		 CTD PMID:21858171 NCBI chr18:25,945,375...25,983,271
Ensembl chr18:25,945,381...25,976,509 		JBrowse link
G Rexo4 REX4 homolog, 3'-5' exonuclease multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of REXO4 mRNA CTD PMID:21858171 NCBI chr 3:10,280,654...10,291,003
Ensembl chr 3:10,280,654...10,290,996 		JBrowse link
G Rfc2 replication factor C subunit 2 decreases expression ISO Piroxicam results in decreased expression of RFC2 mRNA CTD PMID:21858171 NCBI chr12:22,120,449...22,133,576
Ensembl chr12:22,120,010...22,133,557 		JBrowse link
G Rfc3 replication factor C subunit 3 multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of RFC3 mRNA] CTD PMID:21858171 NCBI chr12:1,000,987...1,011,778
Ensembl chr12:1,000,994...1,011,778 		JBrowse link
G Rfc5 replication factor C subunit 5 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of RFC5 mRNA] CTD PMID:21858171 NCBI chr12:39,207,484...39,217,041
Ensembl chr12:39,207,484...39,217,312 		JBrowse link
G Rgs4 regulator of G-protein signaling 4 multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of RGS4 mRNA] CTD PMID:19192274 PMID:21858171 NCBI chr13:81,936,775...81,943,103
Ensembl chr13:81,936,775...81,943,068 		JBrowse link
G Rig1 RNA sensor RIG-1 decreases expression ISO Piroxicam results in decreased expression of RIGI mRNA CTD PMID:19192274 NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819 		JBrowse link
G Ripk2 receptor-interacting serine-threonine kinase 2 decreases expression ISO Piroxicam results in decreased expression of RIPK2 mRNA CTD PMID:19192274 NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:29,631,570...29,662,657 		JBrowse link
G Rnaseh1 ribonuclease H1 increases expression ISO Piroxicam results in increased expression of RNASEH1 mRNA CTD PMID:21858171 NCBI chr 6:45,282,849...45,292,258
Ensembl chr 6:45,282,854...45,292,236 		JBrowse link
G Rnd3 Rho family GTPase 3 increases expression ISO Piroxicam results in increased expression of RND3 mRNA CTD PMID:21858171 NCBI chr 3:35,571,929...35,589,283
Ensembl chr 3:35,571,143...35,589,327 		JBrowse link
G Rnf139 ring finger protein 139 decreases expression ISO Piroxicam results in decreased expression of RNF139 mRNA CTD PMID:21858171 NCBI chr 7:90,439,726...90,450,911
Ensembl chr 7:90,436,621...90,488,009 		JBrowse link
G Rnf19b ring finger protein 19B decreases expression ISO Piroxicam results in decreased expression of RNF19B mRNA CTD PMID:19192274 NCBI chr 5:141,406,085...141,431,376
Ensembl chr 5:141,406,118...141,431,380 		JBrowse link
G Rpa2 replication protein A2 decreases expression ISO Piroxicam results in decreased expression of RPA2 mRNA CTD PMID:21858171 NCBI chr 5:144,976,789...144,989,445
Ensembl chr 5:144,976,748...144,987,350 		JBrowse link
G Rpia ribose 5-phosphate isomerase A decreases expression ISO Piroxicam results in decreased expression of RPIA mRNA CTD PMID:21858171 NCBI chr 4:102,723,712...102,749,374
Ensembl chr 4:102,723,712...102,749,355 		JBrowse link
G Rrm2 ribonucleotide reductase regulatory subunit M2 decreases expression ISO Piroxicam results in decreased expression of RRM2 mRNA CTD PMID:21858171 NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773 		JBrowse link
G Rsad2 radical S-adenosyl methionine domain containing 2 decreases expression ISO Piroxicam results in decreased expression of RSAD2 mRNA CTD PMID:19192274 NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699 		JBrowse link
G Rsu1 Ras suppressor protein 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of RSU1 mRNA CTD PMID:21858171 NCBI chr17:76,128,774...76,377,515
Ensembl chr17:76,188,812...76,377,454 		JBrowse link
G RT1-A2 RT1 class Ia, locus A2 decreases expression ISO Piroxicam results in decreased expression of HLA-E mRNA CTD PMID:21858171 NCBI chr20:4,870,939...4,910,183 JBrowse link
G RT1-CE16 RT1 class I, locus CE16 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HLA-A mRNA CTD PMID:21858171 NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563 		JBrowse link
G RT1-DMb RT1 class II, locus DMb affects expression ISO Piroxicam affects the expression of HLA-DMB mRNA CTD PMID:25811541 NCBI chr20:4,693,102...4,700,340
Ensembl chr20:4,693,103...4,700,340 		JBrowse link
G RT1-M3-1 RT1 class Ib, locus M3, gene 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HLA-G mRNA CTD PMID:21858171 NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117 		JBrowse link
G Rtn3 reticulon 3 increases expression ISO Piroxicam results in increased expression of RTN3 mRNA CTD PMID:21858171 NCBI chr 1:204,612,675...204,669,212
Ensembl chr 1:204,612,675...204,669,275 		JBrowse link
G Rybp RING1 and YY1 binding protein decreases expression ISO Piroxicam results in decreased expression of RYBP mRNA CTD PMID:21858171 NCBI chr 4:132,876,260...132,928,328
Ensembl chr 4:132,876,361...132,928,316 		JBrowse link
G Sap30 Sin3A associated protein 30 decreases expression ISO Piroxicam results in decreased expression of SAP30 mRNA CTD PMID:21858171 NCBI chr16:32,747,777...32,753,114
Ensembl chr16:32,747,734...32,753,112 		JBrowse link
G Sar1a secretion associated, Ras related GTPase 1A decreases expression ISO Piroxicam results in decreased expression of SAR1A mRNA CTD PMID:21858171 NCBI chr20:29,623,529...29,635,935
Ensembl chr20:29,623,553...29,635,935 		JBrowse link
G Sars1 seryl-tRNA synthetase 1 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of SARS1 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SARS1 mRNA]		 CTD PMID:21858171 NCBI chr 2:196,065,543...196,081,240
Ensembl chr 2:196,065,430...196,081,277 		JBrowse link
G Sat1 spermidine/spermine N1-acetyl transferase 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SAT1 mRNA CTD PMID:21858171 NCBI chr  X:40,158,354...40,161,641
Ensembl chr  X:40,157,046...40,196,813 		JBrowse link
G Sav1 salvador family WW domain containing protein 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SAV1 mRNA CTD PMID:21858171 NCBI chr 6:88,478,536...88,500,121
Ensembl chr 6:88,478,539...88,499,968 		JBrowse link
G Scd stearoyl-CoA desaturase decreases expression ISO Piroxicam results in decreased expression of SCD mRNA CTD PMID:21858171 NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562 		JBrowse link
G Scn5a sodium voltage-gated channel alpha subunit 5 decreases activity ISO Piroxicam results in decreased activity of SCN5A protein CTD PMID:33617802 NCBI chr 8:119,220,905...119,318,816
Ensembl chr 8:119,220,905...119,318,769 		JBrowse link
G Sec31a SEC31 homolog A, COPII coat complex component multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SEC31A mRNA CTD PMID:21858171 NCBI chr14:9,214,324...9,269,281
Ensembl chr14:9,214,349...9,269,273 		JBrowse link
G Sel1l SEL1L adaptor subunit of SYVN1 ubiquitin ligase decreases expression ISO Piroxicam results in decreased expression of SEL1L mRNA CTD PMID:21858171 NCBI chr 6:110,735,450...110,779,695
Ensembl chr 6:110,735,450...110,779,648 		JBrowse link
G Selenow selenoprotein W decreases expression ISO Piroxicam results in decreased expression of SELENOW mRNA CTD PMID:21858171 NCBI chr 1:76,599,441...76,604,514
Ensembl chr 1:76,598,779...76,604,724
Ensembl chr 1:76,598,779...76,604,724 		JBrowse link
G Sell selectin L affects expression ISO Piroxicam affects the expression of SELL protein CTD PMID:12147693 NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456 		JBrowse link
G Sephs1 selenophosphate synthetase 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SEPHS1 mRNA CTD PMID:21858171 NCBI chr17:73,354,435...73,382,803
Ensembl chr17:73,356,530...73,382,593 		JBrowse link
G Sertad2 SERTA domain containing 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SERTAD2 mRNA CTD PMID:21858171 NCBI chr14:94,733,637...94,838,200
Ensembl chr14:94,733,579...94,838,313 		JBrowse link
G Sesn1 sestrin 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of SESN1 mRNA CTD PMID:21858171 NCBI chr20:45,294,876...45,387,698
Ensembl chr20:45,294,871...45,387,697 		JBrowse link
G Sf3a3 splicing factor 3a, subunit 3 decreases expression ISO Piroxicam results in decreased expression of SF3A3 mRNA CTD PMID:21858171 NCBI chr 5:136,967,713...136,987,345
Ensembl chr 5:136,967,691...136,987,361 		JBrowse link
G Sh2b3 SH2B adaptor protein 3 increases expression ISO Piroxicam results in increased expression of SH2B3 mRNA CTD PMID:21858171 NCBI chr12:34,731,934...34,753,617
Ensembl chr12:34,731,911...34,753,616 		JBrowse link
G Sh3glb1 SH3 domain -containing GRB2-like endophilin B1 decreases expression ISO Piroxicam results in decreased expression of SH3GLB1 mRNA CTD PMID:21858171 NCBI chr 2:233,750,838...233,784,817
Ensembl chr 2:233,750,838...233,784,784 		JBrowse link
G Shcbp1 SHC binding and spindle associated 1 multiple interactions
increases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in increased expression of SHCBP1 mRNA] CTD PMID:21858171 NCBI chr16:84,672,277...84,703,843
Ensembl chr16:84,672,321...84,703,844 		JBrowse link
G Sinhcaf SIN3-HDAC complex associated factor multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SINHCAF mRNA CTD PMID:21858171 NCBI chr 4:181,888,301...181,913,294
Ensembl chr 4:181,888,312...181,910,276 		JBrowse link
G Siva1 SIVA1, apoptosis-inducing factor multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SIVA1 mRNA] CTD PMID:21858171 NCBI chr 6:131,705,323...131,709,697
Ensembl chr 6:131,705,323...131,709,690 		JBrowse link
G Skp1 S-phase kinase-associated protein 1 decreases expression ISO Piroxicam results in decreased expression of SKP1 mRNA CTD PMID:21858171 NCBI chr10:36,401,987...36,417,066
Ensembl chr10:36,402,153...36,417,388 		JBrowse link
G Skp2 S-phase kinase associated protein 2 decreases expression ISO Piroxicam results in decreased expression of SKP2 mRNA CTD PMID:21858171 NCBI chr 2:58,161,226...58,189,293
Ensembl chr 2:58,161,229...58,189,338 		JBrowse link
G Slc16a1 solute carrier family 16 member 1 multiple interactions
increases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of SLC16A1 mRNA] CTD PMID:21858171 NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 decreases activity ISO Piroxicam results in decreased activity of SLC22A2 protein CTD PMID:12388633 NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268 		JBrowse link
G Slc22a25 solute carrier family 22, member 25 decreases activity ISO Piroxicam results in decreased activity of SLC22A9 protein CTD PMID:12388633 NCBI chr 1:205,338,698...205,498,486
Ensembl chr 1:205,338,699...205,433,085 		JBrowse link
G Slc22a6 solute carrier family 22 member 6 decreases activity
multiple interactions		 ISO
EXP		 Piroxicam results in decreased activity of SLC22A6 protein
Piroxicam inhibits the reaction [SLC22A6 protein results in increased uptake of ochratoxin A]		 CTD PMID:10336520 PMID:12388633 NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173 		JBrowse link
G Slc22a7 solute carrier family 22 member 7 decreases activity ISO Piroxicam results in decreased activity of SLC22A7 protein CTD PMID:12388633 NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921 		JBrowse link
G Slc22a8 solute carrier family 22 member 8 multiple interactions EXP Piroxicam inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate] CTD PMID:10224140 NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450 		JBrowse link
G Slc25a12 solute carrier family 25 member 12 multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of SLC25A12 mRNA] CTD PMID:21858171 NCBI chr 3:56,097,166...56,191,841
Ensembl chr 3:56,097,269...56,192,100 		JBrowse link
G Slc25a13 solute carrier family 25 member 13 multiple interactions
increases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of SLC25A13 mRNA] CTD PMID:21858171 NCBI chr 4:34,179,224...34,361,912
Ensembl chr 4:34,179,224...34,361,902 		JBrowse link
G Slc3a2 solute carrier family 3 member 2 decreases expression ISO Piroxicam results in decreased expression of SLC3A2 mRNA CTD PMID:21858171 NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931 		JBrowse link
G Slc5a3 solute carrier family 5 member 3 increases expression ISO Piroxicam results in increased expression of SLC5A3 mRNA CTD PMID:21858171 NCBI chr11:31,313,847...31,316,293
Ensembl chr11:31,295,476...31,318,883 		JBrowse link
G Slc6a15 solute carrier family 6 member 15 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SLC6A15 mRNA] CTD PMID:21858171 NCBI chr 7:38,553,055...38,607,239
Ensembl chr 7:38,553,196...38,607,239 		JBrowse link
G Slc6a8 solute carrier family 6 member 8 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SLC6A8 mRNA CTD PMID:21858171 NCBI chr  X:151,384,675...151,393,979
Ensembl chr  X:151,384,675...151,393,979 		JBrowse link
G Slc7a11 solute carrier family 7 member 11 decreases expression ISO Piroxicam results in decreased expression of SLC7A11 mRNA CTD PMID:19192274 NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536 		JBrowse link
G Slc7a5 solute carrier family 7 member 5 decreases expression ISO Piroxicam results in decreased expression of SLC7A5 mRNA CTD PMID:21858171 NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823 		JBrowse link
G Slc7a8 solute carrier family 7 member 8 increases expression ISO Piroxicam results in increased expression of SLC7A8 mRNA CTD PMID:19192274 NCBI chr15:28,183,013...28,242,717
Ensembl chr15:28,183,015...28,242,717 		JBrowse link
G Slit2 slit guidance ligand 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of SLIT2 mRNA CTD PMID:21858171 NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948 		JBrowse link
G Smarca5 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 decreases expression ISO Piroxicam results in decreased expression of SMARCA5 mRNA CTD PMID:21858171 NCBI chr19:27,271,918...27,304,594
Ensembl chr19:27,271,148...27,304,594 		JBrowse link
G Smarce1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 decreases expression ISO Piroxicam results in decreased expression of SMARCE1 mRNA CTD PMID:21858171 NCBI chr10:84,159,270...84,180,547
Ensembl chr10:84,159,275...84,179,989 		JBrowse link
G Smc2 structural maintenance of chromosomes 2 decreases expression ISO Piroxicam results in decreased expression of SMC2 mRNA CTD PMID:21858171 NCBI chr 5:66,806,882...66,853,478
Ensembl chr 5:66,807,011...66,853,242 		JBrowse link
G Smc3 structural maintenance of chromosomes 3 decreases expression ISO Piroxicam results in decreased expression of SMC3 mRNA CTD PMID:21858171 NCBI chr 1:252,601,422...252,644,522
Ensembl chr 1:252,601,753...252,644,522 		JBrowse link
G Sms spermine synthase decreases expression ISO Piroxicam results in decreased expression of SMS mRNA CTD PMID:19192274 NCBI chr  X:37,516,949...37,572,657
Ensembl chr  X:37,516,931...37,570,822 		JBrowse link
G Snrnp40 small nuclear ribonucleoprotein U5 subunit 40 decreases expression ISO Piroxicam results in decreased expression of SNRNP40 mRNA CTD PMID:21858171 NCBI chr 5:142,700,632...142,733,776
Ensembl chr 5:142,700,534...142,733,776 		JBrowse link
G Snrpa small nuclear ribonucleoprotein polypeptide A decreases expression ISO Piroxicam results in decreased expression of SNRPA mRNA CTD PMID:21858171 NCBI chr 1:82,481,770...82,490,540
Ensembl chr 1:82,481,770...82,490,538 		JBrowse link
G Snrpa1 small nuclear ribonucleoprotein polypeptide A' increases expression ISO Piroxicam results in increased expression of SNRPA1 mRNA CTD PMID:21858171 NCBI chr 1:119,641,402...119,654,653
Ensembl chr 1:119,638,481...119,654,653 		JBrowse link
G Snrpd1 small nuclear ribonucleoprotein D1 polypeptide multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SNRPD1 mRNA CTD PMID:21858171 NCBI chr18:1,696,838...1,707,400
Ensembl chr18:1,696,852...1,708,256 		JBrowse link
G Snx5 sorting nexin 5 decreases expression ISO Piroxicam results in decreased expression of SNX5 mRNA CTD PMID:21858171 NCBI chr 3:131,621,875...131,641,127
Ensembl chr 3:131,621,880...131,641,192 		JBrowse link
G Sod2 superoxide dismutase 2 decreases expression ISO Piroxicam results in decreased expression of SOD2 mRNA CTD PMID:19192274 NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189 		JBrowse link
G Spag5 sperm associated antigen 5 decreases expression ISO Piroxicam results in decreased expression of SPAG5 mRNA CTD PMID:21858171 NCBI chr10:63,198,717...63,216,746
Ensembl chr10:63,198,768...63,216,745 		JBrowse link
G Sparc secreted protein acidic and cysteine rich decreases expression ISO Piroxicam results in decreased expression of SPARC mRNA CTD PMID:21858171 NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396 		JBrowse link
G Spcs2 signal peptidase complex subunit 2 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of SPCS2 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SPCS2 mRNA]		 CTD PMID:21858171 NCBI chr 1:154,163,724...154,183,152
Ensembl chr 1:154,163,724...154,183,186 		JBrowse link
G Spdl1 spindle apparatus coiled-coil protein 1 increases expression ISO Piroxicam results in increased expression of SPDL1 mRNA CTD PMID:21858171 NCBI chr10:19,269,125...19,294,213
Ensembl chr10:19,269,127...19,294,127 		JBrowse link
G Spp1 secreted phosphoprotein 1 decreases expression ISO Piroxicam results in decreased expression of SPP1 mRNA CTD PMID:21858171 NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162 		JBrowse link
G Sptlc2 serine palmitoyltransferase, long chain base subunit 2 decreases expression ISO Piroxicam results in decreased expression of SPTLC2 mRNA CTD PMID:21858171 NCBI chr 6:106,948,682...107,031,532
Ensembl chr 6:106,950,949...107,031,542 		JBrowse link
G Sqstm1 sequestosome 1 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SQSTM1 mRNA] CTD PMID:21858171 NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673 		JBrowse link
G Srsf1 serine and arginine rich splicing factor 1 increases expression ISO Piroxicam results in increased expression of SRSF1 mRNA CTD PMID:21858171 NCBI chr10:72,838,926...72,859,066
Ensembl chr10:72,839,274...72,845,336 		JBrowse link
G Srsf10 serine and arginine rich splicing factor 10 decreases expression ISO Piroxicam results in decreased expression of SRSF10 mRNA CTD PMID:21858171 NCBI chr 5:148,088,759...148,102,964
Ensembl chr 5:148,088,823...148,101,768 		JBrowse link
G Srsf2 serine and arginine rich splicing factor 2 decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of SRSF2 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SRSF2 mRNA]		 CTD PMID:21858171 NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338 		JBrowse link
G Srsf3 serine and arginine rich splicing factor 3 multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of SRSF3 mRNA] CTD PMID:21858171 NCBI chr20:7,091,928...7,101,860
Ensembl chr20:7,091,910...7,101,078 		JBrowse link
G Srsf6 serine and arginine rich splicing factor 6 decreases expression ISO Piroxicam results in decreased expression of SRSF6 mRNA CTD PMID:21858171 NCBI chr 3:151,589,546...151,594,869
Ensembl chr 3:151,589,535...151,594,860 		JBrowse link
G Srsf7 serine and arginine rich splicing factor 7 decreases expression ISO Piroxicam results in decreased expression of SRSF7 mRNA CTD PMID:21858171 NCBI chr 6:14,811,775...14,818,968
Ensembl chr 6:14,811,808...14,818,965 		JBrowse link
G Ssr3 signal sequence receptor subunit 3 decreases expression ISO Piroxicam results in decreased expression of SSR3 mRNA CTD PMID:21858171 NCBI chr 2:149,605,005...149,625,069
Ensembl chr 2:149,605,005...149,625,132 		JBrowse link
G Ssx2ip SSX family member 2 interacting protein multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of SSX2IP mRNA] CTD PMID:21858171 NCBI chr 2:235,298,012...235,330,750
Ensembl chr 2:235,298,088...235,330,745 		JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of STAT3 mRNA CTD PMID:21858171 NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057 		JBrowse link
G Stat4 signal transducer and activator of transcription 4 decreases expression ISO Piroxicam results in decreased expression of STAT4 mRNA CTD PMID:19192274 NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540 		JBrowse link
G Stc2 stanniocalcin 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of STC2 mRNA CTD PMID:21858171 NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973 		JBrowse link
G Stip1 stress-induced phosphoprotein 1 increases expression ISO Piroxicam results in increased expression of STIP1 mRNA CTD PMID:21858171 NCBI chr 1:204,209,433...204,228,452
Ensembl chr 1:204,178,932...204,228,476 		JBrowse link
G Stk39 serine threonine kinase 39 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of STK39 mRNA CTD PMID:21858171 NCBI chr 3:52,913,583...53,179,060
Ensembl chr 3:52,913,585...53,179,060 		JBrowse link
G Stmn1 stathmin 1 decreases expression ISO Piroxicam results in decreased expression of STMN1 mRNA CTD PMID:21858171 NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154 		JBrowse link
G Sts steroid sulfatase increases expression ISO Piroxicam results in increased expression of STS mRNA CTD PMID:19192274 NCBI chr  X:42,225,131...42,233,403
Ensembl chr  X:42,225,372...42,233,402 		JBrowse link
G Sucla2 succinate-CoA ligase ADP-forming subunit beta decreases expression ISO Piroxicam results in decreased expression of SUCLA2 mRNA CTD PMID:21858171 NCBI chr15:48,752,356...48,805,495
Ensembl chr15:48,752,312...48,805,138 		JBrowse link
G Sult1a1 sulfotransferase family 1A member 1 decreases activity ISO Piroxicam results in decreased activity of SULT1A1 protein CTD PMID:17073578 NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562 		JBrowse link
G Syncrip synaptotagmin binding, cytoplasmic RNA interacting protein increases expression ISO Piroxicam results in increased expression of SYNCRIP mRNA CTD PMID:21858171 NCBI chr 8:89,402,487...89,435,517
Ensembl chr 8:89,402,866...89,435,515 		JBrowse link
G Tcf3 transcription factor 3 decreases expression ISO Piroxicam results in decreased expression of TCF3 mRNA CTD PMID:21858171 NCBI chr 7:9,280,571...9,302,315
Ensembl chr 7:9,280,571...9,302,314 		JBrowse link
G Tdg thymine-DNA glycosylase decreases expression ISO Piroxicam results in decreased expression of TDG mRNA CTD PMID:21858171 NCBI chr 7:21,077,853...21,097,617
Ensembl chr 7:21,077,853...21,097,567 		JBrowse link
G Terf2 telomeric repeat binding factor 2 multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of TERF2 mRNA] CTD PMID:21858171 NCBI chr19:34,976,963...35,005,813
Ensembl chr19:34,977,471...35,005,819 		JBrowse link
G Tfam transcription factor A, mitochondrial decreases expression ISO Piroxicam results in decreased expression of TFAM mRNA CTD PMID:21858171 NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292 		JBrowse link
G Tgfa transforming growth factor alpha multiple interactions EXP Piroxicam promotes the reaction [Hydrochloric Acid results in increased expression of TGFA protein] CTD PMID:15309881 NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894 		JBrowse link
G Tgif1 TGFB-induced factor homeobox 1 decreases expression ISO Piroxicam results in decreased expression of TGIF1 mRNA CTD PMID:21858171 NCBI chr 9:110,748,094...110,757,714
Ensembl chr 9:110,720,921...110,757,802 		JBrowse link
G Tgm2 transglutaminase 2 decreases expression ISO Piroxicam results in decreased expression of TGM2 mRNA CTD PMID:21858171 NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981 		JBrowse link
G Thbs2 thrombospondin 2 increases expression ISO Piroxicam results in increased expression of THBS2 mRNA CTD PMID:19192274 NCBI chr 1:55,670,394...55,699,789
Ensembl chr 1:55,670,394...55,699,789 		JBrowse link
G Thoc2 THO complex subunit 2 increases expression ISO Piroxicam results in increased expression of THOC2 mRNA CTD PMID:21858171 NCBI chr  X:120,634,966...120,749,569
Ensembl chr  X:120,634,968...120,749,513 		JBrowse link
G Timm10 translocase of inner mitochondrial membrane 10 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TIMM10 mRNA CTD PMID:21858171 NCBI chr 3:69,908,397...69,911,943
Ensembl chr 3:69,908,456...69,911,940 		JBrowse link
G Timm13 translocase of inner mitochondrial membrane 13 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TIMM13 mRNA CTD PMID:21858171 NCBI chr 7:8,809,069...8,810,172
Ensembl chr 7:8,809,058...8,809,910 		JBrowse link
G Timm17a translocase of inner mitochondrial membrane 17A decreases expression ISO Piroxicam results in decreased expression of TIMM17A mRNA CTD PMID:21858171 NCBI chr13:46,731,117...46,742,604
Ensembl chr13:46,730,660...46,742,655 		JBrowse link
G Timm23 translocase of inner mitochondrial membrane 23 increases expression ISO Piroxicam results in increased expression of TIMM23 mRNA CTD PMID:21858171 NCBI chr16:7,410,308...7,436,392
Ensembl chr16:7,409,688...7,436,379 		JBrowse link
G Tipin timeless interacting protein multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of TIPIN mRNA] CTD PMID:21858171 NCBI chr 8:64,780,813...64,801,358
Ensembl chr 8:64,780,828...64,801,352 		JBrowse link
G Tjp2 tight junction protein 2 multiple interactions
increases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of TJP2 mRNA] CTD PMID:21858171 NCBI chr 1:221,709,745...221,838,291
Ensembl chr 1:221,709,745...221,838,295 		JBrowse link
G Tk1 thymidine kinase 1 decreases expression ISO Piroxicam results in decreased expression of TK1 mRNA CTD PMID:21858171 NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920 		JBrowse link
G Tlr2 toll-like receptor 2 decreases expression ISO Piroxicam results in decreased expression of TLR2 mRNA CTD PMID:19192274 NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630 		JBrowse link
G Tm4sf1 transmembrane 4 L six family member 1 decreases expression ISO Piroxicam results in decreased expression of TM4SF1 mRNA CTD PMID:21858171 NCBI chr 2:141,456,950...141,466,146
Ensembl chr 2:141,453,310...141,466,146 		JBrowse link
G Tmed7 transmembrane p24 trafficking protein 7 increases expression ISO Piroxicam results in increased expression of TMED7 mRNA CTD PMID:21858171 NCBI chr18:39,318,564...39,325,640
Ensembl chr18:39,297,351...39,325,640 		JBrowse link
G Tmem158 transmembrane protein 158 decreases expression ISO Piroxicam results in decreased expression of TMEM158 mRNA CTD PMID:21858171 NCBI chr 8:122,913,675...122,914,673
Ensembl chr 8:122,913,675...122,914,673 		JBrowse link
G Tmem43 transmembrane protein 43 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TMEM43 mRNA CTD PMID:21858171 NCBI chr 4:123,977,680...123,992,823
Ensembl chr 4:123,977,625...123,992,825 		JBrowse link
G Tmpo thymopoietin multiple interactions
increases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of TMPO mRNA] CTD PMID:21858171 NCBI chr 7:25,642,752...25,667,756
Ensembl chr 7:25,586,725...25,667,727 		JBrowse link
G Tmx1 thioredoxin-related transmembrane protein 1 decreases expression ISO Piroxicam results in decreased expression of TMX1 mRNA CTD PMID:21858171 NCBI chr 6:88,960,691...88,971,744
Ensembl chr 6:88,960,695...88,971,301 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO Piroxicam inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
[Piroxicam co-treated with Lipopolysaccharides] results in increased secretion of TNF protein		 CTD PMID:10328874 PMID:17328244 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Topbp1 DNA topoisomerase II binding protein 1 decreases expression ISO Piroxicam results in decreased expression of TOPBP1 mRNA CTD PMID:21858171 NCBI chr 8:103,887,805...103,931,662
Ensembl chr 8:103,887,865...103,931,674 		JBrowse link
G Tp53 tumor protein p53 multiple interactions ISO Piroxicam promotes the reaction [Cisplatin results in increased expression of TP53 protein] CTD PMID:21858171 NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524 		JBrowse link
G Tra2a transformer 2 alpha multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of TRA2A mRNA CTD PMID:21858171 NCBI chr 4:78,220,838...78,239,737
Ensembl chr 4:78,220,883...78,239,712 		JBrowse link
G Traf3ip2 Traf3 interacting protein 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TRAF3IP2 mRNA CTD PMID:21858171 NCBI chr20:43,011,405...43,054,654
Ensembl chr20:43,011,450...43,054,667 		JBrowse link
G Trappc4 trafficking protein particle complex subunit 4 decreases expression ISO Piroxicam results in decreased expression of TRAPPC4 mRNA CTD PMID:21858171 NCBI chr 8:44,729,458...44,733,285
Ensembl chr 8:44,725,331...44,733,491 		JBrowse link
G Trhde thyrotropin-releasing hormone degrading enzyme decreases expression
multiple interactions		 ISO Piroxicam results in decreased expression of TRHDE mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of TRHDE mRNA]		 CTD PMID:21858171 NCBI chr 7:49,943,271...50,350,613
Ensembl chr 7:49,945,766...50,367,371 		JBrowse link
G Trib3 tribbles pseudokinase 3 decreases expression ISO Piroxicam results in decreased expression of TRIB3 mRNA CTD PMID:21858171 NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497 		JBrowse link
G Trim28 tripartite motif-containing 28 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TRIM28 mRNA CTD PMID:21858171 NCBI chr 1:73,652,441...73,659,388
Ensembl chr 1:73,652,709...73,659,380 		JBrowse link
G Tsc22d1 TSC22 domain family, member 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TSC22D1 mRNA CTD PMID:21858171 NCBI chr15:51,750,489...51,850,958
Ensembl chr15:51,749,510...51,850,958 		JBrowse link
G Tspan6 tetraspanin 6 decreases expression ISO Piroxicam results in decreased expression of TSPAN6 mRNA CTD PMID:21858171 NCBI chr  X:97,092,394...97,099,659
Ensembl chr  X:97,092,388...97,099,309 		JBrowse link
G Ttc3 tetratricopeptide repeat domain 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of TTC3 mRNA CTD PMID:21858171 NCBI chr11:33,689,119...33,788,976
Ensembl chr11:33,688,952...33,788,975 		JBrowse link
G Ttk Ttk protein kinase multiple interactions
decreases expression		 ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of TTK mRNA] CTD PMID:21858171 NCBI chr 8:84,754,329...84,792,653
Ensembl chr 8:84,754,315...84,792,651 		JBrowse link
G Tuba1a tubulin, alpha 1A decreases expression ISO Piroxicam results in decreased expression of TUBA1A mRNA CTD PMID:21858171 NCBI chr 7:130,113,214...130,116,880
Ensembl chr 7:130,081,032...130,196,186 		JBrowse link
G Txndc9 thioredoxin domain containing 9 multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of TXNDC9 mRNA] CTD PMID:21858171 NCBI chr 9:40,211,818...40,221,953
Ensembl chr 9:40,211,412...40,384,279
Ensembl chr 9:40,211,412...40,384,279 		JBrowse link
G Txnip thioredoxin interacting protein multiple interactions
decreases expression
increases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of TXNIP mRNA]
Piroxicam results in increased expression of TXNIP mRNA		 CTD PMID:19192274 PMID:21858171 NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886 		JBrowse link
G Ube2a ubiquitin-conjugating enzyme E2A decreases expression ISO Piroxicam results in decreased expression of UBE2A mRNA CTD PMID:21858171 NCBI chr  X:116,114,339...116,125,076
Ensembl chr  X:116,113,875...116,125,070 		JBrowse link
G Ube2b ubiquitin-conjugating enzyme E2B multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of UBE2B mRNA] CTD PMID:21858171 NCBI chr10:36,248,434...36,263,379
Ensembl chr10:36,248,438...36,264,665 		JBrowse link
G Ube2l3 ubiquitin-conjugating enzyme E2L 3 increases expression ISO Piroxicam results in increased expression of UBE2L3 mRNA CTD PMID:21858171 NCBI chr11:83,797,722...83,838,862
Ensembl chr11:83,797,722...83,838,862 		JBrowse link
G Ube2n ubiquitin-conjugating enzyme E2N multiple interactions
decreases expression		 ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of UBE2N mRNA] CTD PMID:21858171 NCBI chr 7:30,154,330...30,184,373
Ensembl chr 7:30,154,616...30,184,355 		JBrowse link
G Ubr7 ubiquitin protein ligase E3 component n-recognin 7 decreases expression ISO Piroxicam results in decreased expression of UBR7 mRNA CTD PMID:21858171 NCBI chr 6:121,898,613...121,918,480
Ensembl chr 6:121,898,623...121,918,477 		JBrowse link
G Uchl5 ubiquitin C-terminal hydrolase L5 decreases expression ISO Piroxicam results in decreased expression of UCHL5 mRNA CTD PMID:21858171 NCBI chr13:55,520,722...55,556,503
Ensembl chr13:55,520,729...55,556,502 		JBrowse link
G Ung uracil-DNA glycosylase decreases expression ISO Piroxicam results in decreased expression of UNG mRNA CTD PMID:21858171 NCBI chr12:42,485,276...42,494,217
Ensembl chr12:42,485,276...42,494,206 		JBrowse link
G Usp1 ubiquitin specific peptidase 1 decreases expression ISO Piroxicam results in decreased expression of USP1 mRNA CTD PMID:21858171 NCBI chr 5:113,587,564...113,598,934
Ensembl chr 5:113,587,564...113,598,932 		JBrowse link
G Usp16 ubiquitin specific peptidase 16 increases expression ISO Piroxicam results in increased expression of USP16 mRNA CTD PMID:21858171 NCBI chr11:26,681,359...26,711,313
Ensembl chr11:26,681,414...26,710,539 		JBrowse link
G Usp46 ubiquitin specific peptidase 46 decreases expression ISO Piroxicam results in decreased expression of USP46 mRNA CTD PMID:21858171 NCBI chr14:34,150,055...34,219,227
Ensembl chr14:34,150,004...34,219,227 		JBrowse link
G Utp11 UTP11, small subunit processome component decreases expression ISO Piroxicam results in decreased expression of UTP11 mRNA CTD PMID:21858171 NCBI chr 5:136,931,279...136,946,164
Ensembl chr 5:136,931,008...136,946,191 		JBrowse link
G Vcp valosin-containing protein decreases expression ISO Piroxicam results in decreased expression of VCP mRNA CTD PMID:21858171 NCBI chr 5:57,210,167...57,229,571
Ensembl chr 5:57,210,168...57,229,571 		JBrowse link
G Vdac3 voltage-dependent anion channel 3 decreases expression ISO Piroxicam results in decreased expression of VDAC3 mRNA CTD PMID:21858171 NCBI chr16:69,434,982...69,451,473
Ensembl chr16:69,435,005...69,451,471 		JBrowse link
G Vegfa vascular endothelial growth factor A decreases expression ISO Piroxicam results in decreased expression of VEGFA mRNA CTD PMID:21858171 NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641 		JBrowse link
G Vps28 VPS28 subunit of ESCRT-I decreases expression ISO Piroxicam results in decreased expression of VPS28 mRNA CTD PMID:21858171 NCBI chr 7:108,341,989...108,345,837
Ensembl chr 7:108,341,989...108,345,837 		JBrowse link
G Vrk1 VRK serine/threonine kinase 1 decreases expression ISO Piroxicam results in decreased expression of VRK1 mRNA CTD PMID:21858171 NCBI chr 6:124,914,770...124,981,508
Ensembl chr 6:124,914,855...124,981,436 		JBrowse link
G Vrk2 VRK serine/threonine kinase 2 decreases expression ISO Piroxicam results in decreased expression of VRK2 mRNA CTD PMID:21858171 NCBI chr14:100,313,771...100,434,520
Ensembl chr14:100,313,601...100,434,527 		JBrowse link
G Wars1 tryptophanyl-tRNA synthetase 1 decreases expression ISO Piroxicam results in decreased expression of WARS1 mRNA CTD PMID:21858171 NCBI chr 6:127,776,088...127,807,273
Ensembl chr 6:127,776,090...127,807,269 		JBrowse link
G Xpc XPC complex subunit, DNA damage recognition and repair factor multiple interactions
decreases expression		 ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of XPC mRNA] CTD PMID:21858171 NCBI chr 4:123,993,670...124,020,922
Ensembl chr 4:123,993,666...124,021,010 		JBrowse link
G Xpot exportin for tRNA decreases expression ISO Piroxicam results in decreased expression of XPOT mRNA CTD PMID:21858171 NCBI chr 7:57,111,536...57,152,013
Ensembl chr 7:57,111,536...57,152,099 		JBrowse link
G Ybx3 Y box binding protein 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of YBX3 mRNA CTD PMID:21858171 NCBI chr 4:165,129,747...165,153,101
Ensembl chr 4:165,129,758...165,153,161 		JBrowse link
G Ywhab tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta increases expression ISO Piroxicam results in increased expression of YWHAB mRNA CTD PMID:21858171 NCBI chr 3:152,659,663...152,682,105
Ensembl chr 3:152,659,651...152,682,105 		JBrowse link
G Zfp110 zinc finger protein 110 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of ZNF274 mRNA CTD PMID:21858171 NCBI chr 1:73,445,303...73,461,112
Ensembl chr 1:73,445,336...73,461,086 		JBrowse link
G Zfp207 zinc finger protein 207 decreases expression ISO Piroxicam results in decreased expression of ZNF207 mRNA CTD PMID:21858171 NCBI chr10:65,385,807...65,398,086
Ensembl chr10:65,385,740...65,397,386 		JBrowse link
G Zfp36l2 zinc finger protein 36, C3H type-like 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of ZFP36L2 mRNA CTD PMID:21858171 NCBI chr 6:10,490,032...10,494,073
Ensembl chr 6:10,490,032...10,494,064 		JBrowse link
G Zmat3 zinc finger, matrin type 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of ZMAT3 mRNA CTD PMID:21858171 NCBI chr 2:115,106,046...115,136,888
Ensembl chr 2:115,106,966...115,136,863 		JBrowse link
G Zmpste24 zinc metallopeptidase STE24 decreases expression ISO Piroxicam results in decreased expression of ZMPSTE24 mRNA CTD PMID:21858171 NCBI chr 5:134,627,218...134,660,360
Ensembl chr 5:134,627,229...134,660,110 		JBrowse link
G Zmynd8 zinc finger, MYND-type containing 8 decreases expression ISO Piroxicam results in decreased expression of ZMYND8 mRNA CTD PMID:21858171 NCBI chr 3:154,528,917...154,629,532
Ensembl chr 3:154,529,043...154,628,463 		JBrowse link
G Zwilch zwilch kinetochore protein increases expression ISO Piroxicam results in increased expression of ZWILCH mRNA CTD PMID:21858171 NCBI chr 8:64,638,401...64,670,911
Ensembl chr 8:64,637,672...64,675,916 		JBrowse link
G Zwint ZW10 interacting kinetochore protein decreases expression ISO Piroxicam results in decreased expression of ZWINT mRNA CTD PMID:21858171 NCBI chr20:15,938,157...15,953,997
Ensembl chr20:15,938,157...15,953,957 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19911
    chemical entity 19909
      atom 19909
        nonmetal atom 19832
          nitrogen atom 19009
            nitrogen molecular entity 18984
              organonitrogen compound 18859
                organonitrogen heterocyclic compound 18174
                  benzothiazine 614
                    (4-anilino-1,1-dioxo-2H-1$l^\{6\},2-benzothiazin-3-yl)-phenylmethanone 0
                    1,2,3,4a-tetrahydrophenothiazin-4-one 0
                    1,4-Benzothiazine-O-quinonimine 0
                    1-(3,5-dimethylphenyl)-3-(4-methyl-3-oxo-1,4-benzothiazin-6-yl)urea 0
                    1-(4-ethoxyphenyl)-3-(4-methyl-3-oxo-1,4-benzothiazin-6-yl)urea 0
                    10-(3-aminopropyl)-8-chlorophenothiazine-2,3-dione 0
                    2,2-dimethyl-3,4a-dihydro-1H-phenothiazin-4-one 0
                    2-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]thiazin-2-yl)-N-hydroxyacetamide 0
                    2-[(2-chlorophenyl)methylidene]-4-methyl-3-oxo-N-(3-pyridinylmethyl)-1,4-benzothiazine-6-carboxamide 0
                    2-[3-[2-[4-(benzenesulfonyl)-1-piperazinyl]-2-oxoethyl]-4-oxo-1,3-benzothiazin-2-ylidene]acetonitrile 0
                    2-methyl-1,1,4-trioxo-N-(2-pyridinyl)-3H-1$l^\{6\},2-benzothiazine-3-carboxamide 0
                    2-methyl-N-(5-methyl-2-thiazolyl)-1,1,4-trioxo-3H-1$l^\{6\},2-benzothiazine-3-carboxamide 0
                    2-methyl-N-(5-methyl-3-isoxazolyl)-1,1,4-trioxo-3H-1$l^\{6\},2-benzothiazine-3-carboxamide 0
                    3-(3-nitrophenyl)-2-nitroso-4H-1,4-benzothiazine 0
                    3-oxo-4H-1,4-benzothiazine-6-carboxylic acid [2-[1-(1-methoxypropan-2-yl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl] ester 0
                    4-[[2-[(3-methylphenyl)methylidene]-3-oxo-4H-1,4-benzothiazin-6-yl]-oxomethyl]-1-piperazinecarboxylic acid ethyl ester 0
                    4-[[[4-[(4-fluorophenyl)methyl]-2,3-dihydro-1,4-benzothiazin-6-yl]-oxomethyl]amino]-1-piperidinecarboxylic acid ethyl ester 0
                    4-[[oxo-[4-(phenylmethyl)-2,3-dihydro-1,4-benzothiazin-6-yl]methyl]amino]-1-piperidinecarboxylic acid ethyl ester 0
                    4-methyl-2,3-dihydro-1,4-benzothiazine-6-carboxylic acid methyl ester 0
                    5'-Carboxy meloxicam 0
                    5'-Hydroxy meloxicam 0
                    5'-Hydroxypiroxicam 0
                    5'-hydroxymethyl-5'-desmethylmeloxicam 0
                    5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide 0
                    7-(2-amino-2-carboxyethyl)-5-hydroxy-2H-1,4-benzothiazine-3-carboxylic acid 0
                    7-(2-amino-2-carboxyethyl)-5-hydroxy-3,4-dihydro-2H-1,4-benzothiazin-3-one 0
                    7-hydroxy-4H-1,4-benzothiazin-3-one 0
                    7-hydroxy-5,6,8-tris(methylsulanyl)-4H-1,4-benzothiazin-3-one 0
                    7-hydroxy-5,8-bis(methylsulanyl)-4H-1,4-benzothiazin-3-one 0
                    7-hydroxy-5-hydroxymethyl-2H-benzo[1,4]thiazin-3-one 0
                    8-chloro-1,2,3,4a-tetrahydrophenothiazin-4-one 0
                    8-chloro-10-[3-(dimethylamino)-2-hydroxypropyl]phenothiazine-2,3-dione 0
                    9-methyl-5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide 0
                    9-methyl-6H-benzo[c][1,2]benzothiazine 5,5-dioxide 0
                    Gliomastin B 0
                    Herbimycin D 0
                    Leptothiazinone A 0
                    Leptothiazinone B 0
                    N-[(3-methoxyphenyl)methyl]-4H-3,1-benzothiazin-2-amine 0
                    N-[(4-methoxyphenyl)methyl]-4-methyl-1,3-dioxo-1$l^\{4\},4-benzothiazine-6-carboxamide 0
                    N-[(5-bromo-2-methoxyphenyl)methyl]-4-methyl-2,3-dihydro-1,4-benzothiazine-6-carboxamide 0
                    N-[2-(2,5-dimethoxyphenyl)ethyl]-4-[(4-fluorophenyl)methyl]-2,3-dihydro-1,4-benzothiazine-6-carboxamide 0
                    N-[2-(4-morpholinyl)ethyl]-4-(phenylmethyl)-2,3-dihydro-1,4-benzothiazine-6-carboxamide 0
                    N-[3-(1-azepanyl)propyl]-2-(4-morpholinyl)-3-oxo-4H-1,4-benzothiazine-6-carboxamide 0
                    N-[3-(4-methyl-1-piperazinyl)propyl]-4-(phenylmethyl)-2,3-dihydro-1,4-benzothiazine-6-carboxamide 0
                    N-[3-[butyl(ethyl)amino]propyl]-2-[6-(4-morpholinylsulfonyl)-3-oxo-1,4-benzothiazin-4-yl]acetamide 0
                    N-\{2-[6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-1,4-benzothiazin-4-yl]ethyl\}acetamide 0
                    ampiroxicam 0
                    ethyl 2-[4-(2H-1,4-benzothiazin-3-yl)piperazin-1-yl]-1,3-thiazole-4-carboxylate 0
                    isoxicam 0
                    meloxicam 35
                    piroxicam + 588
Path 2
Term Annotations click to browse term
  CHEBI ontology 19911
    subatomic particle 19909
      composite particle 19909
        hadron 19880
          baryon 19880
            nucleon 19909
              atomic nucleus 19880
                atom 19909
                  main group element atom 19849
                    p-block element atom 19849
                      carbon group element atom 19766
                        carbon atom 19785
                          organic molecular entity 19785
                            organic molecule 19737
                              organic cyclic compound 19526
                                organic heterocyclic compound 18870
                                  organic heteropolycyclic compound 18315
                                    organic heterobicyclic compound 17265
                                      benzothiazine 614
                                        (4-anilino-1,1-dioxo-2H-1$l^\{6\},2-benzothiazin-3-yl)-phenylmethanone 0
                                        1,2,3,4a-tetrahydrophenothiazin-4-one 0
                                        1,4-Benzothiazine-O-quinonimine 0
                                        1-(3,5-dimethylphenyl)-3-(4-methyl-3-oxo-1,4-benzothiazin-6-yl)urea 0
                                        1-(4-ethoxyphenyl)-3-(4-methyl-3-oxo-1,4-benzothiazin-6-yl)urea 0
                                        10-(3-aminopropyl)-8-chlorophenothiazine-2,3-dione 0
                                        2,2-dimethyl-3,4a-dihydro-1H-phenothiazin-4-one 0
                                        2-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]thiazin-2-yl)-N-hydroxyacetamide 0
                                        2-[(2-chlorophenyl)methylidene]-4-methyl-3-oxo-N-(3-pyridinylmethyl)-1,4-benzothiazine-6-carboxamide 0
                                        2-[3-[2-[4-(benzenesulfonyl)-1-piperazinyl]-2-oxoethyl]-4-oxo-1,3-benzothiazin-2-ylidene]acetonitrile 0
                                        2-methyl-1,1,4-trioxo-N-(2-pyridinyl)-3H-1$l^\{6\},2-benzothiazine-3-carboxamide 0
                                        2-methyl-N-(5-methyl-2-thiazolyl)-1,1,4-trioxo-3H-1$l^\{6\},2-benzothiazine-3-carboxamide 0
                                        2-methyl-N-(5-methyl-3-isoxazolyl)-1,1,4-trioxo-3H-1$l^\{6\},2-benzothiazine-3-carboxamide 0
                                        3-(3-nitrophenyl)-2-nitroso-4H-1,4-benzothiazine 0
                                        3-oxo-4H-1,4-benzothiazine-6-carboxylic acid [2-[1-(1-methoxypropan-2-yl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl] ester 0
                                        4-[[2-[(3-methylphenyl)methylidene]-3-oxo-4H-1,4-benzothiazin-6-yl]-oxomethyl]-1-piperazinecarboxylic acid ethyl ester 0
                                        4-[[[4-[(4-fluorophenyl)methyl]-2,3-dihydro-1,4-benzothiazin-6-yl]-oxomethyl]amino]-1-piperidinecarboxylic acid ethyl ester 0
                                        4-[[oxo-[4-(phenylmethyl)-2,3-dihydro-1,4-benzothiazin-6-yl]methyl]amino]-1-piperidinecarboxylic acid ethyl ester 0
                                        4-methyl-2,3-dihydro-1,4-benzothiazine-6-carboxylic acid methyl ester 0
                                        5'-Carboxy meloxicam 0
                                        5'-Hydroxy meloxicam 0
                                        5'-Hydroxypiroxicam 0
                                        5'-hydroxymethyl-5'-desmethylmeloxicam 0
                                        5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide 0
                                        7-(2-amino-2-carboxyethyl)-5-hydroxy-2H-1,4-benzothiazine-3-carboxylic acid 0
                                        7-(2-amino-2-carboxyethyl)-5-hydroxy-3,4-dihydro-2H-1,4-benzothiazin-3-one 0
                                        7-hydroxy-4H-1,4-benzothiazin-3-one 0
                                        7-hydroxy-5,6,8-tris(methylsulanyl)-4H-1,4-benzothiazin-3-one 0
                                        7-hydroxy-5,8-bis(methylsulanyl)-4H-1,4-benzothiazin-3-one 0
                                        7-hydroxy-5-hydroxymethyl-2H-benzo[1,4]thiazin-3-one 0
                                        8-chloro-1,2,3,4a-tetrahydrophenothiazin-4-one 0
                                        8-chloro-10-[3-(dimethylamino)-2-hydroxypropyl]phenothiazine-2,3-dione 0
                                        9-methyl-5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide 0
                                        9-methyl-6H-benzo[c][1,2]benzothiazine 5,5-dioxide 0
                                        Gliomastin B 0
                                        Herbimycin D 0
                                        Leptothiazinone A 0
                                        Leptothiazinone B 0
                                        N-[(3-methoxyphenyl)methyl]-4H-3,1-benzothiazin-2-amine 0
                                        N-[(4-methoxyphenyl)methyl]-4-methyl-1,3-dioxo-1$l^\{4\},4-benzothiazine-6-carboxamide 0
                                        N-[(5-bromo-2-methoxyphenyl)methyl]-4-methyl-2,3-dihydro-1,4-benzothiazine-6-carboxamide 0
                                        N-[2-(2,5-dimethoxyphenyl)ethyl]-4-[(4-fluorophenyl)methyl]-2,3-dihydro-1,4-benzothiazine-6-carboxamide 0
                                        N-[2-(4-morpholinyl)ethyl]-4-(phenylmethyl)-2,3-dihydro-1,4-benzothiazine-6-carboxamide 0
                                        N-[3-(1-azepanyl)propyl]-2-(4-morpholinyl)-3-oxo-4H-1,4-benzothiazine-6-carboxamide 0
                                        N-[3-(4-methyl-1-piperazinyl)propyl]-4-(phenylmethyl)-2,3-dihydro-1,4-benzothiazine-6-carboxamide 0
                                        N-[3-[butyl(ethyl)amino]propyl]-2-[6-(4-morpholinylsulfonyl)-3-oxo-1,4-benzothiazin-4-yl]acetamide 0
                                        N-\{2-[6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-1,4-benzothiazin-4-yl]ethyl\}acetamide 0
                                        ampiroxicam 0
                                        ethyl 2-[4-(2H-1,4-benzothiazin-3-yl)piperazin-1-yl]-1,3-thiazole-4-carboxylate 0
                                        isoxicam 0
                                        meloxicam 35
                                        piroxicam + 588
paths to the root